1
|
Henriksson L, Sandstedt M, Nowik P, Persson A. Automated AI-based coronary calcium scoring using retrospective CT data from SCAPIS is accurate and correlates with expert scoring. Eur Radiol 2024:10.1007/s00330-024-11118-3. [PMID: 39419864 DOI: 10.1007/s00330-024-11118-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2024] [Revised: 07/09/2024] [Accepted: 09/05/2024] [Indexed: 10/19/2024]
Abstract
OBJECTIVES Evaluation of the correlation and agreement between AI and semi-automatic evaluations of calcium scoring CT (CSCT) examinations using extensive data from the Swedish CardioPulmonary bio-Image study (SCAPIS). MATERIALS AND METHODS In total, 5057 CSCT examinations were performed on one CT system at Linköping University Hospital between October 8, 2015, and June 12, 2018. AI evaluations were compared to semi-automatic CSCT results from expert reader evaluations rendered within SCAPIS. Pearson correlation, intraclass correlation coefficients (ICC), and Bland-Altman analysis were applied for Agatston (AS), volume (VS), mass scores (MS), number of lesions and lesion location. Agreement of Agatston score classifications into cardiovascular (CV) risk categories was evaluated with weighted kappa analysis. RESULTS The evaluation included 4567 subjects, 2229 (48.8%) male, 2338 (51.2%) female, 50-64 years of age (mean 57.3 ± 4.4). The AS ranged from 0 to 2871 in the cohort, with 2846 subjects having an AS of 0. Mean and median AS were 51.4 and 0.0, respectively. Total AS, VS, MS and number of lesions ICCs were 0.994, 0.994, 0.994, 0.960 (p < 0.001), respectively. Bland-Altman analyses rendered mean differences ± 1.96 SD upper and lower limits of agreement for AS -0.04, -52.5 to 52.4, VS -0.44, -46.51 to 45.63, and MS -0.07, -9.62 to 9.48. Weighted kappa analysis for CV risk category classifications was 0.913, and overall accuracy was 91.2%. CONCLUSION There was excellent correlation and agreement between AI and semi-automatic evaluations for all calcium scores, number of lesions and lesion location. High degrees of agreement and accuracy were found for the CV risk categorization. KEY POINTS Question Can AI function as a tool for enhancing the efficiency and accuracy of Coronary Artery Calcium Score (CACS) evaluations in clinical radiology practice? Findings This study confirms the robustness of AI-derived CACS results across extensive datasets, though its generalizability is limited by data acquisition from a single CT system. Clinical relevance This study suggests that AI holds significant promise as a tool for enhancing the efficiency and accuracy of CACS evaluations, with implications for improving patient diagnostics and reducing radiologist workload in clinical practice.
Collapse
Affiliation(s)
- Lilian Henriksson
- Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden.
- Unit of Radiology, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
| | - Mårten Sandstedt
- Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden
- Unit of Radiology, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden
| | - Patrik Nowik
- Department of Clinical Science Intervention and Technology, CLINTEC, Karolinska Institutet, Stockholm, Sweden
- Siemens Healthineers, Stockholm, Sweden
| | - Anders Persson
- Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden
- Unit of Radiology, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden
- Department of Clinical Science Intervention and Technology, CLINTEC, Karolinska Institutet, Stockholm, Sweden
| |
Collapse
|
2
|
Rajiah PS, Budoff M, Ghoshhajra B, Morris MF, Ocazionez-Trujillo D, Ordovas K, Patel AR, Ranganath P, Vargas D, Woodard PK, Choi AD. Training and Verification Requirements for Interpretation of Cardiac CT and MRI: AJR Expert Panel Narrative Review. AJR Am J Roentgenol 2024. [PMID: 38984783 DOI: 10.2214/ajr.24.31524] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/11/2024]
Abstract
The use of cardiac CT and MRI is rapidly expanding based on strong evidence from large international trials. The number of physicians competent to interpret cardiac CT and MRI may be unable to keep pace with the increasing demand. Societies and organizations have prescribed training requirements for interpreting cardiac CT and MRI, with recent updates focusing on the increased breadth of competency that is now required due to ongoing imaging advances. In this AJR Expert Panel Narrative Review, we discuss several aspects of cardiac CT and MRI training, focusing on topics that are uncertain or not addressed in existing society statements and guidelines, including determination of competency in different practice types in real-world settings and the impact of artificial intelligence on training and education. The article is intended to guide updates in professional society training requirements and also inform institutional verification processes.
Collapse
Affiliation(s)
| | - Matthew Budoff
- Department of Cardiology, Lundquist Institute, Torrance, California, USA
| | - Brian Ghoshhajra
- Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA
| | | | | | - Karen Ordovas
- Department of Radiology, UW Medical Center, Seattle, Washington, USA
| | - Amit R Patel
- Division of Cardiovascular Diseases, University of Virginia, Virginia, USA
| | | | - Daniel Vargas
- Department of Radiology, University of Colorado-School of Medicine, Denver, Colorado, USA
| | - Pamela K Woodard
- Department of Radiology, Mallinckrodt Institute of Radiology, ST. Louis, Missouri, USA
| | - Andrew D Choi
- Department of Cardiology, George Washington University Hospital, Washington DC, USA
| |
Collapse
|
3
|
Li D, Mao SS, Budoff MJ. Trabecular bone mineral density as measured by thoracic vertebrae predicts incident hip and vertebral fractures: the multi-ethnic study of atherosclerosis. Osteoporos Int 2024; 35:1061-1068. [PMID: 38519739 DOI: 10.1007/s00198-024-07040-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/02/2023] [Accepted: 02/12/2024] [Indexed: 03/25/2024]
Abstract
We evaluated the relationship of bone mineral density (BMD) by computed tomography (CT), to predict fractures in a multi-ethnic population. We demonstrated that vertebral and hip fractures were more likely in those patients with low BMD. This is one of the first studies to demonstrate that CT BMD derived from thoracic vertebrae can predict future hip and vertebral fractures. PURPOSE/INTRODUCTION Osteoporosis affects an enormous number of patients, of all races and both sexes, and its prevalence increases as the population ages. Few studies have evaluated the association between the vertebral trabecular bone mineral density(vBMD) and osteoporosis-related hip fracture in a multiethnic population, and no studies have demonstrated the predictive value of vBMD for fractures. METHOD We sought to determine the predictive value of QCT-based trabecular vBMD of thoracic vertebrae derived from coronary artery calcium scan for hip fractures in the Multi-Ethnic Study of Atherosclerosis(MESA), a nationwide multicenter cohort included 6814 people from six medical centers across the USA and assess if low bone density by QCT can predict future fractures. Measures were done using trabecular bone measures, adjusted for individual patients, from three consecutive thoracic vertebrae (BDI Inc, Manhattan Beach CA, USA) from non-contrast cardiac CT scans. RESULTS Six thousand eight hundred fourteen MESA baseline participants were included with a mean age of 62.2 ± 10.2 years, and 52.8% were women. The mean thoracic BMD is 162.6 ± 46.8 mg/cm3 (95% CI 161.5, 163.7), and 27.6% of participants (n = 1883) had osteoporosis (T-score 2.5 or lower). Over a median follow-up of 17.4 years, Caucasians have a higher rate of vertebral fractures (6.9%), followed by Blacks (4.4%), Hispanics (3.7%), and Chinese (3.0%). Hip fracture patients had a lower baseline vBMD as measured by QCT than the non-hip fracture group by 13.6 mg/cm3 [P < 0.001]. The same pattern was seen in the vertebral fracture population, where the mean BMD was substantially lower 18.3 mg/cm3 [P < 0.001] than in the non-vertebral fracture population. Notably, the above substantial relationship was unaffected by age, gender, race, BMI, hypertension, current smoking, medication use, or activity. Patients with low trabecular BMD of thoracic vertebrae showed a 1.57-fold greater risk of first hip fracture (HR 1.57, 95% CI 1.38-1.95) and a nearly threefold increased risk of first vertebral fracture (HR 2.93, 95% CI 1.87-4.59) compared to normal BMD patients. CONCLUSION There is significant correlation between thoracic trabecular BMD and the incidence of future hip and vertebral fracture. This study demonstrates that thoracic vertebrae BMD, as measured on cardiac CT (QCT), can predict both hip and vertebral fractures without additional radiation, scanning, or patient burden. Osteopenia and osteoporosis are markedly underdiagnosed. Finding occult disease affords the opportunity to treat the millions of people undergoing CT scans every year for other indications.
Collapse
Affiliation(s)
- Dong Li
- Division of Hospital Medicine, Emory School of Medicine, 201 Dowman Dr, Atlanta, GA, 30322, USA
| | - Song Shou Mao
- The Lundquist Institute at Harbor-UCLA Medical Center, 1124 West Carson Street, Torrance, CA, 90502, USA
| | - Matthew J Budoff
- The Lundquist Institute at Harbor-UCLA Medical Center, 1124 West Carson Street, Torrance, CA, 90502, USA.
| |
Collapse
|
4
|
Aboyewa OB, Laternser C, Popescu A, Murphy N, Shah D, Monge MC, Rigsby CK, Golestanirad L, Webster G, Kim D. Cumulative radiation dose from medical imaging in paediatric congenital heart disease patients with epicardial cardiac implantable electronic devices. EUROPEAN HEART JOURNAL. IMAGING METHODS AND PRACTICE 2024; 2:qyae060. [PMID: 39045197 PMCID: PMC11251694 DOI: 10.1093/ehjimp/qyae060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/06/2024] [Accepted: 05/23/2024] [Indexed: 07/25/2024]
Abstract
Aims To determine whether paediatric congenital heart disease (CHD) patients with epicardial cardiac implantable electronic devices (CIEDs) receive high cumulative effective doses (CEDs) of ionizing radiation from medical imaging tests. Methods and results We compared 28 paediatric CHD patients with epicardial CIEDs (cases) against 40 patients with no CIED matched by age at operation, sex, surgical era, and CHD diagnosis (controls). We performed a retrospective review of radiation exposure from medical imaging exams between 2006 and 2022. Radiation dose from computed tomography (CT) and X-ray radiography was calculated using the National Cancer Institute Radiation Dosimetry Tool. We performed univariate analysis to compare the CED between the two groups. In the case subgroup, we convened experts' review to adjudicate the prevalence of CT exams that should have been performed with magnetic resonance imaging (MRI) in the absence of a CIED. Children (median age 2.5 years at implant) with CIEDs received significantly higher median CED compared with matched controls (6.90 vs. 1.72 mSv, P = 0.0018). In cases, expert adjudication showed that 80% of the CT exams would have been performed with MRI in the absence of a CIED. This resulted, on average, a five-fold increase in the effective dose (ED) from post-lead implant CTs. Conclusion Paediatric CHD patients with CIED received four times higher CED than matched controls. Improved access to medical imaging tests without ionizing radiation, such as MRI, could potentially reduce the ED in CIED patients by up to five times.
Collapse
Affiliation(s)
- Oluyemi B Aboyewa
- Department of Biomedical Engineering, Northwestern University, 2145 Sheridan Road, E310, Evanston, IL 60208, USA
- Department of Radiology, Feinberg School of Medicine, Northwestern University, 737 N. Michigan Avenue Suite 1600, Chicago, IL 60611, USA
| | - Christina Laternser
- Division of Cardiology, Department of Pediatrics, Ann & Robert H. Lurie Children’s Hospital, 225 E Chicago Avenue, Chicago, IL 60611, USA
| | - Andrada Popescu
- Department of Medical Imaging, Ann & Robert H. Lurie Children’s Hospital, 225 E Chicago Avenue, Chicago, IL 60611, USA
| | - Nicole Murphy
- Department of Medical Imaging, Ann & Robert H. Lurie Children’s Hospital, 225 E Chicago Avenue, Chicago, IL 60611, USA
| | - Dhaivat Shah
- Division of Cardiology, Department of Pediatrics, Ann & Robert H. Lurie Children’s Hospital, 225 E Chicago Avenue, Chicago, IL 60611, USA
| | - Michael C Monge
- Division of Cardiovascular Surgery, Department of Surgery, Ann & Robert H. Lurie Children’s Hospital, 225 E Chicago Avenue, Chicago, IL 60611, USA
| | - Cynthia K Rigsby
- Department of Medical Imaging, Ann & Robert H. Lurie Children’s Hospital, 225 E Chicago Avenue, Chicago, IL 60611, USA
| | - Laleh Golestanirad
- Department of Biomedical Engineering, Northwestern University, 2145 Sheridan Road, E310, Evanston, IL 60208, USA
- Department of Radiology, Feinberg School of Medicine, Northwestern University, 737 N. Michigan Avenue Suite 1600, Chicago, IL 60611, USA
| | - Gregory Webster
- Division of Cardiology, Department of Pediatrics, Ann & Robert H. Lurie Children’s Hospital, 225 E Chicago Avenue, Chicago, IL 60611, USA
| | - Daniel Kim
- Department of Biomedical Engineering, Northwestern University, 2145 Sheridan Road, E310, Evanston, IL 60208, USA
- Department of Radiology, Feinberg School of Medicine, Northwestern University, 737 N. Michigan Avenue Suite 1600, Chicago, IL 60611, USA
| |
Collapse
|
5
|
Intravenous Contrast Material for Cardiac Computed Tomography: Results From the Open-label Multicenter, Multivendor Italian Registry of Contrast Material Use in Cardiac Computed Tomography. J Thorac Imaging 2023; 38:128-135. [PMID: 36821381 DOI: 10.1097/rti.0000000000000644] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
PURPOSE The Italian Registry of Contrast Material use in Cardiac Computed Tomography (iRCM-CCT) is a multicenter, multivendor, observational study on the use of contrast media (CM) in patients undergoing cardiac computed tomography (CCT). The aim of iRCM-CCT is to assess image quality and safety profile of intravenous CM compounds. MATERIALS AND METHODS iRCM-CCT enrolled 1842 consecutive patients undergoing CCT (≥50 per site) at 20 cluster sites with the indication of suspected coronary artery disease. Demographic characteristics, CCT, and CM protocols, clinical indications, safety markers, radiation dose reports, qualitative (ie, poor vascular enhancement) and quantitative (ie, HU attenuation values) image parameters were recorded. A centralized coordinating center collected and assessed all image parameters. RESULTS The cohort included 891 men and 951 women (age: 63±14 y, body mass index: 26±4 kg/m2) studied with ≥64 detector rows computed tomography scanners and different iodinated intravenous CM protocols and compounds (iodixanol, iopamidol, iohexol, iobitridol, iopromide, and iomeprol). The following vascular attenuation was reported: 504±147 HU in the aorta, 451±146 HU in the right coronary artery, 474±146 HU in the left main, 451±146 HU in the left anterior descending artery, and 441±149 HU in the circumflex artery. In 4% of cases the image quality was not satisfactory due to poor enhancement. The following adverse reactions to CM were recorded: 6 (0.3%) extravasations and 17 (0.9%) reactions (11 mild, 4 moderate, 2 severe). CONCLUSIONS In a multicenter registry on CM use during CCT the prevalence of CM-related adverse reactions was very low. The appropriate use of CM is a major determinant of image quality.
Collapse
|
6
|
Han X, He Y, Luo N, Zheng D, Hong M, Wang Z, Yang Z. The influence of artificial intelligence assistance on the diagnostic performance of CCTA for coronary stenosis for radiologists with different levels of experience. Acta Radiol 2023; 64:496-507. [PMID: 35389276 DOI: 10.1177/02841851221089263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND The interpretation of coronary computed tomography angiography (CCTA) stenosis may be difficult among radiologists of different experience levels. Artificial intelligence (AI) may improve the diagnostic performance. PURPOSE To investigate whether the diagnostic performance and time efficiency of radiologists with different levels of experience in interpreting CCTA images could be improved by using CCTA with AI assistance (CCTA-AI). MATERIAL AND METHODS This analysis included 200 patients with complete CCTA and invasive coronary angiography (ICA) data, using ICA results as the reference. Eighteen radiologists were divided into three levels based on experience (Levels I, II, and III), and the three levels were divided into groups without (Groups 1, 2, and 3) and with (Groups 4, 5, and 6) AI assistance, totaling six groups (to avoid reader recall bias). The average sensitivity, specificity, NPV, PPV, and AUC were reported for the six groups and CCTA-AI at the patient, vessel, and segment levels. The interpretation time in the groups with and without CCTA-AI was recorded. RESULTS Compared to the corresponding group without CCTA-AI, the Level I group with CCTA-AI had improved sensitivity (75.0% vs. 83.0% on patient-based; P = 0.003). At Level III, the specificity was better with CCTA-AI. The median interpretation times for the groups with and without CCTA-AI were 413 and 615 s, respectively (P < 0.001). CONCLUSION CCTA-AI could assist with and improve the diagnostic performance of radiologists with different experience levels, with Level I radiologists exhibiting improved sensitivity and Level III radiologists exhibiting improved specificity. The use of CCTA-AI could shorten the training time for radiologists.
Collapse
Affiliation(s)
- Xianjun Han
- Department of Radiology, Beijing Friendship Hospital, 535066Capital Medical University, Beijing, PR China
| | - Yi He
- Department of Radiology, Beijing Friendship Hospital, 535066Capital Medical University, Beijing, PR China
| | - Nan Luo
- Department of Radiology, Beijing Friendship Hospital, 535066Capital Medical University, Beijing, PR China
| | - Dandan Zheng
- Shukun (Beijing) Technology Co., Ltd., Beijing, PR China
| | - Min Hong
- Department of Computer Software Engineering, 37969Soonchunhyang University, Asan, Republic of Korea
| | - Zhenchang Wang
- Department of Radiology, Beijing Friendship Hospital, 535066Capital Medical University, Beijing, PR China
| | - Zhenghan Yang
- Department of Radiology, Beijing Friendship Hospital, 535066Capital Medical University, Beijing, PR China
| |
Collapse
|
7
|
Tveit SH, Myhre PL, Hanssen TA, Forsdahl SH, Iqbal A, Omland T, Schirmer H. Cardiac troponin I and T for ruling out coronary artery disease in suspected chronic coronary syndrome. Sci Rep 2022; 12:945. [PMID: 35042885 PMCID: PMC8766564 DOI: 10.1038/s41598-022-04850-7] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2021] [Accepted: 12/17/2021] [Indexed: 01/20/2023] Open
Abstract
To compare the performance of high-sensitivity cardiac troponin I and T (hs-cTnI; hs-cTnT) in diagnosing obstructive coronary artery disease (CAD50) in patients with suspected chronic coronary syndrome (CCS). A total of 706 patients with suspected CCS, referred for Coronary Computed Tomography Angiography, were included. cTn concentrations were measured using the Singulex hs-cTnI (limit of detection [LoD] 0.08 ng/L) and Roche hs-cTnT (LoD 3 ng/L) assays. Obstructive coronary artery disease (CAD50) was defined as ≥ 50% coronary stenosis. Cardiovascular risk was determined by the NORRISK2-score. Median age of the patients was 65 (range 28-87) years, 35% were women. All patients had hs-cTnI concentrations above the LoD (median 1.9 [Q1-3 1.2-3.6] ng/L), 72% had hs-cTnT above the LoD (median 5 [Q1-3 2-11] ng/L). There was a graded relationship between hs-cTn concentrations and coronary artery calcium. Only hs-cTnI remained associated with CAD50 in adjusted analyses (OR 1.20 95% Confidence Interval [1.05-1.38]), p = 0.009). The C-statistics for hs-cTnI and hs-cTnT were 0.65 (95% CI [0.60-0.69]) and 0.60 (0.56-0.64). The highest specificity and negative predictive values for CAD50 were in the lowest NORRISK2-tertile. hs-cTn concentrations provide diagnostic information in patients with suspected CCS, with superior performance of hs-cTnI compared to hs-cTnT in regard to CAD50. The diagnostic performance appeared best in those with low cardiovascular risk.
Collapse
Affiliation(s)
- Sjur H Tveit
- Department of Cardiology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway.,Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
| | - Peder L Myhre
- Department of Cardiology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway.,Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
| | - Tove Aminda Hanssen
- Department of Health and Care Science, UiT - The Arctic University of Norway, Tromsø, Norway.,Department of Cardiology, University Hospital of North Norway, Tromsø, Norway
| | | | - Amjid Iqbal
- Department of Cardiology, University Hospital of North Norway, Tromsø, Norway
| | - Torbjørn Omland
- Department of Cardiology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway.,Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
| | - Henrik Schirmer
- Department of Cardiology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway. .,Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
| |
Collapse
|
8
|
Bergström G, Persson M, Adiels M, Björnson E, Bonander C, Ahlström H, Alfredsson J, Angerås O, Berglund G, Blomberg A, Brandberg J, Börjesson M, Cederlund K, de Faire U, Duvernoy O, Ekblom Ö, Engström G, Engvall JE, Fagman E, Eriksson M, Erlinge D, Fagerberg B, Flinck A, Gonçalves I, Hagström E, Hjelmgren O, Lind L, Lindberg E, Lindqvist P, Ljungberg J, Magnusson M, Mannila M, Markstad H, Mohammad MA, Nystrom FH, Ostenfeld E, Persson A, Rosengren A, Sandström A, Själander A, Sköld MC, Sundström J, Swahn E, Söderberg S, Torén K, Östgren CJ, Jernberg T. Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population. Circulation 2021; 144:916-929. [PMID: 34543072 PMCID: PMC8448414 DOI: 10.1161/circulationaha.121.055340] [Citation(s) in RCA: 192] [Impact Index Per Article: 64.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Supplemental Digital Content is available in the text. Background: Early detection of coronary atherosclerosis using coronary computed tomography angiography (CCTA), in addition to coronary artery calcification (CAC) scoring, may help inform prevention strategies. We used CCTA to determine the prevalence, severity, and characteristics of coronary atherosclerosis and its association with CAC scores in a general population. Methods: We recruited 30 154 randomly invited individuals age 50 to 64 years to SCAPIS (the Swedish Cardiopulmonary Bioimage Study). The study includes individuals without known coronary heart disease (ie, no previous myocardial infarctions or cardiac procedures) and with high-quality results from CCTA and CAC imaging performed using dedicated dual-source CT scanners. Noncontrast images were scored for CAC. CCTA images were visually read and scored for coronary atherosclerosis per segment (defined as no atherosclerosis, 1% to 49% stenosis, or ≥50% stenosis). External validity of prevalence estimates was evaluated using inverse probability for participation weighting and Swedish register data. Results: In total, 25 182 individuals without known coronary heart disease were included (50.6% women). Any CCTA-detected atherosclerosis was found in 42.1%; any significant stenosis (≥50%) in 5.2%; left main, proximal left anterior descending artery, or 3-vessel disease in 1.9%; and any noncalcified plaques in 8.3% of this population. Onset of atherosclerosis was delayed on average by 10 years in women. Atherosclerosis was more prevalent in older individuals and predominantly found in the proximal left anterior descending artery. Prevalence of CCTA-detected atherosclerosis increased with increasing CAC scores. Among those with a CAC score >400, all had atherosclerosis and 45.7% had significant stenosis. In those with 0 CAC, 5.5% had atherosclerosis and 0.4% had significant stenosis. In participants with 0 CAC and intermediate 10-year risk of atherosclerotic cardiovascular disease according to the pooled cohort equation, 9.2% had CCTA-verified atherosclerosis. Prevalence estimates had excellent external validity and changed marginally when adjusted to the age-matched Swedish background population. Conclusions: Using CCTA in a large, random sample of the general population without established disease, we showed that silent coronary atherosclerosis is common in this population. High CAC scores convey a significant probability of substantial stenosis, and 0 CAC does not exclude atherosclerosis, particularly in those at higher baseline risk.
Collapse
Affiliation(s)
- Göran Bergström
- Department of Molecular and Clinical Medicine (G. Bergström, E.B., O.A., B.F., O.H., A.R.), University of Gothenburg, Sweden.,Departments of Clinical Physiology (G. Bergström, O.H.), Region Västra Götaland, Gothenburg, Sweden
| | - Margaretha Persson
- Department of Clinical Sciences (M.P., G. Berglund, G.E., M. Magnusson), Lund University, Malmö, Sweden.,Departments of Internal Medicine (M.P.), Skåne University Hospital, Malmö, Sweden
| | - Martin Adiels
- Sahlgrenska Academy, and School of Public Health and Community Medicine, Institute of Medicine (M.A., C.B.), University of Gothenburg, Sweden
| | - Elias Björnson
- Department of Molecular and Clinical Medicine (G. Bergström, E.B., O.A., B.F., O.H., A.R.), University of Gothenburg, Sweden
| | - Carl Bonander
- Sahlgrenska Academy, and School of Public Health and Community Medicine, Institute of Medicine (M.A., C.B.), University of Gothenburg, Sweden
| | - Håkan Ahlström
- Section of Radiology, Department of Surgical Sciences (H.A., O.D.), Uppsala University, Sweden
| | - Joakim Alfredsson
- Departments of Cardiology (J.A., E.S.), Linköping University, Sweden.,Health, Medicine and Caring Sciences (J.A., E.S., J.E.E., F.H.N., C.J.Ö., A.P.), Linköping University, Sweden
| | - Oskar Angerås
- Department of Molecular and Clinical Medicine (G. Bergström, E.B., O.A., B.F., O.H., A.R.), University of Gothenburg, Sweden.,Cardiology (O.A.), Region Västra Götaland, Gothenburg, Sweden
| | - Göran Berglund
- Department of Clinical Sciences (M.P., G. Berglund, G.E., M. Magnusson), Lund University, Malmö, Sweden
| | - Anders Blomberg
- Department of Public Health and Clinical Medicine, Medicine and Heart Centre (A.B., J.L., A. Sandström, A. Själander, S.S.), Umeå University, Sweden
| | - John Brandberg
- Department of Radiology, Institute of Clinical Sciences (J.B., E.F., A.F.), University of Gothenburg, Sweden.,Radiology (J.B., E.F., A.F.), Region Västra Götaland, Gothenburg, Sweden
| | - Mats Börjesson
- Institute of Medicine (M.B.), University of Gothenburg, Sweden.,Center for Health and Performance (M.B.), University of Gothenburg, Sweden.,Sahlgrenska University Hospital (M.B., B.F., A.R., K.T.), Region Västra Götaland, Gothenburg, Sweden
| | - Kerstin Cederlund
- Department of Clinical Science, Intervention and Technology (K.C.), Karolinska Institutet, Stockholm, Sweden
| | - Ulf de Faire
- Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine (U.d.F.), Karolinska Institutet, Stockholm, Sweden
| | - Olov Duvernoy
- Section of Radiology, Department of Surgical Sciences (H.A., O.D.), Uppsala University, Sweden
| | - Örjan Ekblom
- Department of Physical Activity and Health, The Swedish School of Sport and Health Sciences (GIH), Stockholm, Sweden (Ö.E.)
| | - Gunnar Engström
- Department of Clinical Sciences (M.P., G. Berglund, G.E., M. Magnusson), Lund University, Malmö, Sweden
| | - Jan E Engvall
- Health, Medicine and Caring Sciences (J.A., E.S., J.E.E., F.H.N., C.J.Ö., A.P.), Linköping University, Sweden.,Clinical Physiology (J.E.E.), Linköping University, Sweden.,CMIV, Centre of Medical Image Science and Visualization (J.E.E., A.P., C.J.Ö.), Linköping University, Sweden
| | - Erika Fagman
- Department of Radiology, Institute of Clinical Sciences (J.B., E.F., A.F.), University of Gothenburg, Sweden.,Radiology (J.B., E.F., A.F.), Region Västra Götaland, Gothenburg, Sweden
| | - Mats Eriksson
- Department of Endocrinology, Metabolism & Diabetes and Clinical Research Center, Karolinska University Hospital Huddinge, Stockholm, Sweden (M.E.)
| | - David Erlinge
- Department of Clinical Sciences Lund, Cardiology, Lund University and Skåne University Hospital, Lund, Sweden (D.E., M.A.M.)
| | - Björn Fagerberg
- Department of Molecular and Clinical Medicine (G. Bergström, E.B., O.A., B.F., O.H., A.R.), University of Gothenburg, Sweden.,Sahlgrenska University Hospital (M.B., B.F., A.R., K.T.), Region Västra Götaland, Gothenburg, Sweden
| | - Agneta Flinck
- Department of Radiology, Institute of Clinical Sciences (J.B., E.F., A.F.), University of Gothenburg, Sweden.,Radiology (J.B., E.F., A.F.), Region Västra Götaland, Gothenburg, Sweden
| | - Isabel Gonçalves
- Department of Clinical Sciences Malmö (I.G.), Lund University and Skåne University Hospital, Lund, Sweden
| | - Emil Hagström
- Cardiology (E.H.), Uppsala University, Sweden.,Department of Medical Sciences, and Uppsala Clinical Research Center (E.H.), Uppsala University, Sweden
| | - Ola Hjelmgren
- Department of Molecular and Clinical Medicine (G. Bergström, E.B., O.A., B.F., O.H., A.R.), University of Gothenburg, Sweden.,Departments of Clinical Physiology (G. Bergström, O.H.), Region Västra Götaland, Gothenburg, Sweden
| | - Lars Lind
- Clinical Epidemiology (L.L., J.S.), Uppsala University, Sweden
| | - Eva Lindberg
- Respiratory, Allergy and Sleep Research (E.L.), Uppsala University, Sweden
| | - Per Lindqvist
- Department of Surgical and Perioperative Sciences (P.L.), Umeå University, Sweden
| | - Johan Ljungberg
- Department of Public Health and Clinical Medicine, Medicine and Heart Centre (A.B., J.L., A. Sandström, A. Själander, S.S.), Umeå University, Sweden
| | - Martin Magnusson
- Department of Clinical Sciences (M.P., G. Berglund, G.E., M. Magnusson), Lund University, Malmö, Sweden.,Cardiology (M. Magnusson), Skåne University Hospital, Malmö, Sweden.,Wallenberg Center for Molecular Medicine, Lund University, Sweden (M. Magnusson).,North-West University, Hypertension in Africa Research Team (HART), Potchefstroom, South Africa (M. Magnusson)
| | - Maria Mannila
- Heart and Vascular Theme, Department of Cardiology, and Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden (M. Mannila)
| | - Hanna Markstad
- Experimental Cardiovascular Research, Clinical Research Center, Clinical Sciences Malmö (H.M.), Lund University, Malmö, Sweden.,Center for Medical Imaging and Physiology (H.M.), Lund University and Skåne University Hospital, Lund, Sweden
| | - Moman A Mohammad
- Department of Clinical Sciences Lund, Cardiology, Lund University and Skåne University Hospital, Lund, Sweden (D.E., M.A.M.)
| | - Fredrik H Nystrom
- Health, Medicine and Caring Sciences (J.A., E.S., J.E.E., F.H.N., C.J.Ö., A.P.), Linköping University, Sweden
| | - Ellen Ostenfeld
- Department of Clinical Sciences Lund, Clinical Physiology (E.O.), Lund University and Skåne University Hospital, Lund, Sweden
| | - Anders Persson
- Health, Medicine and Caring Sciences (J.A., E.S., J.E.E., F.H.N., C.J.Ö., A.P.), Linköping University, Sweden.,Radiology (A.P.), Linköping University, Sweden.,CMIV, Centre of Medical Image Science and Visualization (J.E.E., A.P., C.J.Ö.), Linköping University, Sweden
| | - Annika Rosengren
- Department of Molecular and Clinical Medicine (G. Bergström, E.B., O.A., B.F., O.H., A.R.), University of Gothenburg, Sweden.,Sahlgrenska University Hospital (M.B., B.F., A.R., K.T.), Region Västra Götaland, Gothenburg, Sweden
| | - Anette Sandström
- Department of Public Health and Clinical Medicine, Medicine and Heart Centre (A.B., J.L., A. Sandström, A. Själander, S.S.), Umeå University, Sweden
| | - Anders Själander
- Department of Public Health and Clinical Medicine, Medicine and Heart Centre (A.B., J.L., A. Sandström, A. Själander, S.S.), Umeå University, Sweden
| | - Magnus C Sköld
- Respiratory Medicine Unit, Department of Medicine Solna and Center for Molecular Medicine (M.C.S.), Karolinska Institutet, Stockholm, Sweden.,Department of Respiratory Medicine and Allergy, Karolinska University Hospital Solna, Stockholm, Sweden (M.C.S.)
| | - Johan Sundström
- Clinical Epidemiology (L.L., J.S.), Uppsala University, Sweden.,The George Institute for Global Health, University of New South Wales, Sydney, Australia (J.S.)
| | - Eva Swahn
- Departments of Cardiology (J.A., E.S.), Linköping University, Sweden.,Health, Medicine and Caring Sciences (J.A., E.S., J.E.E., F.H.N., C.J.Ö., A.P.), Linköping University, Sweden
| | - Stefan Söderberg
- Department of Public Health and Clinical Medicine, Medicine and Heart Centre (A.B., J.L., A. Sandström, A. Själander, S.S.), Umeå University, Sweden
| | - Kjell Torén
- Occupational and Environmental Medicine/School of Public Health and Community Medicine (K.T.), University of Gothenburg, Sweden.,Sahlgrenska University Hospital (M.B., B.F., A.R., K.T.), Region Västra Götaland, Gothenburg, Sweden
| | - Carl Johan Östgren
- Health, Medicine and Caring Sciences (J.A., E.S., J.E.E., F.H.N., C.J.Ö., A.P.), Linköping University, Sweden.,CMIV, Centre of Medical Image Science and Visualization (J.E.E., A.P., C.J.Ö.), Linköping University, Sweden
| | - Tomas Jernberg
- Department of Clinical Sciences, Danderyd University Hospital (T.J.), Karolinska Institutet, Stockholm, Sweden
| |
Collapse
|
9
|
Sanad MH, Marzook FA, Rizvi SFA, Farag AB, Fouzy ASM. Radioiodinated Azilsartan as a New Highly Selective Radiotracer for Myocardial Perfusion Imaging. RADIOCHEMISTRY 2021. [DOI: 10.1134/s1066362221040160] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
10
|
Choi AD, Ferencik M, Leipsic J, Williams MC, Villines TC. Training and competency in cardiovascular computed tomography: Collaborative paradigm for the rising tide. J Cardiovasc Comput Tomogr 2021; 15:88-90. [PMID: 33281096 DOI: 10.1016/j.jcct.2020.11.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- Andrew D Choi
- Division of Cardiology & Department of Radiology, The George Washington University, School of Medicine, Washington, DC, United States.
| | - Maros Ferencik
- Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR, United States
| | - Jonathon Leipsic
- Departments of Medicine and Radiology, University of British Columbia, Vancouver, BC, Canada
| | - Michelle C Williams
- University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom
| | - Todd C Villines
- Division of Cardiovascular Medicine, University of Virginia Health System, Charlottesville, VA, United States
| |
Collapse
|
11
|
Radiosynthesis, chromatographic evaluation and biodistribution of [125I]iododobutamine as a radiotracer for myocardial perfusion imaging. J Radioanal Nucl Chem 2020. [DOI: 10.1007/s10967-020-07120-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
12
|
Cuocolo R, Ponsiglione A, Dell'Aversana S, D'Acierno L, Lassandro G, Ugga L, Romeo V, Vola EA, Stanzione A, Verde F, Picariello V, Capaldo I, Pontillo G, Cantoni V, Green R, Petretta M, Cuocolo A, Imbriaco M. The cardiac conundrum: a systematic review and bibliometric analysis of authorship in cardiac magnetic resonance imaging studies. Insights Imaging 2020; 11:42. [PMID: 32107649 PMCID: PMC7046856 DOI: 10.1186/s13244-020-00850-1] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2020] [Accepted: 02/11/2020] [Indexed: 02/08/2023] Open
Abstract
PURPOSE We aimed to assess the role of radiologists, cardiologists, and other medical and non-medical figures in cardiac magnetic resonance imaging (MRI) research in the last 34 years, focusing on first and last authorship, number of published studies, and journal impact factors (IF). METHODS Articles in the field of cardiac MRI were considered in this systematic review and retrospective bibliometric analysis. For included studies, the first and last authors were categorized as cardiologists, radiologists/nuclear medicine physicians, medical doctors (MD) with specialties in both cardiology and radiology/nuclear medicine, and other MD and non-MD. Differences in the number of papers published overall and by year and institution location for the first and last author category were assessed. Mean IF differences between author categories were also investigated. RESULTS A total of 2053 articles were included in the final analysis. For the first authors (n = 2011), 52% were cardiologists, 22% radiologists/nuclear medicine physicians, 16% other MD, 10% other non-MD, and 1% both cardiologists and radiologists/nuclear medicine physicians. Similarly, the last authors (n = 2029) resulted 54% cardiologists, 22% radiologists/nuclear medicine physicians, 15% other MD, 8% other non-MD, and 2% both cardiologists and radiologists/nuclear medicine physicians. No significant differences due to institution location in the first and last authorship proportions were found. Average journal IF was significantly higher for cardiologist first and last authors when compared to that of radiologists/nuclear medicine physicians (both p < 0.0001). CONCLUSION Over 50% of studies in the field of cardiac MRI published in the last 34 years are conducted by cardiologists.
Collapse
Affiliation(s)
- Renato Cuocolo
- Department of Advanced Biomedical Sciences, University Federico II, Sergio Pansini 5, 80138, Naples, Italy
| | - Andrea Ponsiglione
- Department of Advanced Biomedical Sciences, University Federico II, Sergio Pansini 5, 80138, Naples, Italy.
| | - Serena Dell'Aversana
- Department of Advanced Biomedical Sciences, University Federico II, Sergio Pansini 5, 80138, Naples, Italy
| | - Ludovica D'Acierno
- Department of Advanced Biomedical Sciences, University Federico II, Sergio Pansini 5, 80138, Naples, Italy
| | - Giulia Lassandro
- Department of Advanced Biomedical Sciences, University Federico II, Sergio Pansini 5, 80138, Naples, Italy
| | - Lorenzo Ugga
- Department of Advanced Biomedical Sciences, University Federico II, Sergio Pansini 5, 80138, Naples, Italy
| | - Valeria Romeo
- Department of Advanced Biomedical Sciences, University Federico II, Sergio Pansini 5, 80138, Naples, Italy
| | - Elena Augusta Vola
- Department of Advanced Biomedical Sciences, University Federico II, Sergio Pansini 5, 80138, Naples, Italy
| | - Arnaldo Stanzione
- Department of Advanced Biomedical Sciences, University Federico II, Sergio Pansini 5, 80138, Naples, Italy
| | - Francesco Verde
- Department of Advanced Biomedical Sciences, University Federico II, Sergio Pansini 5, 80138, Naples, Italy
| | - Valentina Picariello
- Department of Advanced Biomedical Sciences, University Federico II, Sergio Pansini 5, 80138, Naples, Italy
| | - Iolanda Capaldo
- Department of Advanced Biomedical Sciences, University Federico II, Sergio Pansini 5, 80138, Naples, Italy
| | - Giuseppe Pontillo
- Department of Advanced Biomedical Sciences, University Federico II, Sergio Pansini 5, 80138, Naples, Italy
| | - Valeria Cantoni
- Department of Advanced Biomedical Sciences, University Federico II, Sergio Pansini 5, 80138, Naples, Italy
| | - Roberta Green
- Department of Advanced Biomedical Sciences, University Federico II, Sergio Pansini 5, 80138, Naples, Italy
| | - Mario Petretta
- Department of Translational Medical Sciences, University Federico II, Naples, Italy
| | - Alberto Cuocolo
- Department of Advanced Biomedical Sciences, University Federico II, Sergio Pansini 5, 80138, Naples, Italy
| | - Massimo Imbriaco
- Department of Advanced Biomedical Sciences, University Federico II, Sergio Pansini 5, 80138, Naples, Italy
| |
Collapse
|
13
|
Affiliation(s)
| | - Edward D Nicol
- Departments of Cardiology and Radiology, Royal Brompton and Harefield NHS Foundation Trust, London, UK
| |
Collapse
|
14
|
O’Leary JM, McNeely DE, Damp JA, Wells QS, Nanney L, Mendes L. Hands-on Gross Anatomy Instruction Improves Clinical Imaging Skills Among Cardiovascular Fellows. JOURNAL OF MEDICAL EDUCATION AND CURRICULAR DEVELOPMENT 2019; 6:2382120519842542. [PMID: 31065587 PMCID: PMC6488777 DOI: 10.1177/2382120519842542] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/03/2019] [Accepted: 03/07/2019] [Indexed: 06/09/2023]
Abstract
INTRODUCTION Multi-modality imaging is a crucial component of cardiovascular (CV) fellowship training and requires knowledge of CV anatomy for interpretation. We hypothesized that hands-on anatomy education would improve the imaging interpretation skills of CV fellows. METHODS The first-year CV fellowship class completed a hands-on cadaveric anatomy session correlated with clinical imaging. Fellows' ability to identify CV structures on cardiac imaging was assessed using a 30-question assessment tool administered at baseline and 1 week and 6 months post intervention. Advanced CV fellows (second or third year) who had not attended the session were also tested. Scores were expressed as median [interquartile range]. RESULTS Among 9 first-year fellows, the majority reported no formal anatomy training since medical school (N = 7) and rated their knowledge of CV anatomy as fair or poor (N = 7) prior to the intervention. The median assessment score was higher 1 week after intervention vs baseline (24 [23-25] vs 19 [17-21]; P = .013) and remained higher than baseline at 6 months (26 [26-28] vs 19 [17-21]; P = .009). The 6-month post-intervention score for first-year fellows was not significantly different than that of senior fellows (n = 10) not exposed to the intervention (26 [26-28] vs 26 [23-27]; P = .434). CONCLUSIONS Gross anatomy instruction improved first-year CV fellows' interpretation of CV imaging. Anatomic instruction may be a useful adjunct to multi-modality imaging education.
Collapse
Affiliation(s)
- JM O’Leary
- Division of Cardiovascular Medicine,
Vanderbilt University Medical Center, Nashville, TN, USA
| | - DE McNeely
- Cardiology Department, Greenville Health
System, Greenville, SC, USA
| | - JA Damp
- Division of Cardiovascular Medicine,
Vanderbilt University Medical Center, Nashville, TN, USA
| | - QS Wells
- Division of Cardiovascular Medicine,
Vanderbilt University Medical Center, Nashville, TN, USA
| | - L Nanney
- Department of Cell and Developmental
Biology, School of Medicine, Vanderbilt University, Nashville, TN, USA
| | - L Mendes
- Division of Cardiovascular Medicine,
Vanderbilt University Medical Center, Nashville, TN, USA
| |
Collapse
|
15
|
Hirshfeld JW, Ferrari VA, Bengel FM, Bergersen L, Chambers CE, Einstein AJ, Eisenberg MJ, Fogel MA, Gerber TC, Haines DE, Laskey WK, Limacher MC, Nichols KJ, Pryma DA, Raff GL, Rubin GD, Smith D, Stillman AE, Thomas SA, Tsai TT, Wagner LK, Samuel Wann L, Januzzi JL, Afonso LC, Everett B, Hernandez AF, Hucker W, Jneid H, Kumbhani D, Edward Marine J, Morris PB, Piana RN, Watson KE, Wiggins BS. 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness. Catheter Cardiovasc Interv 2018; 92:E35-E97. [DOI: 10.1002/ccd.27659] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
|
16
|
Kim RJ, Simonetti OP, Westwood M, Kramer CM, Narang A, Friedrich MG, Powell AJ, Carr JC, Schulz-Menger J, Nagel E, Chan WS, Bremerich J, Ordovas KG, Rollings RC, Patel AR, Ferrari VA. Guidelines for training in cardiovascular magnetic resonance (CMR). J Cardiovasc Magn Reson 2018; 20:57. [PMID: 30111368 PMCID: PMC6094559 DOI: 10.1186/s12968-018-0481-8] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2018] [Accepted: 07/19/2018] [Indexed: 11/10/2022] Open
Abstract
These "Guidelines for training in Cardiovascular Magnetic Resonance" were developed by the Certification Committee of the Society for Cardiovascular Magnetic Resonance (SCMR) and approved by the SCMR Board of Trustees.
Collapse
Affiliation(s)
- R. J. Kim
- Duke University Medical Center, Durham, USA
| | | | | | - C. M. Kramer
- University of Virginia Health System, Charlottesville, USA
| | - A. Narang
- University of Chicago Medicine, Chicago, USA
| | | | | | | | | | - E. Nagel
- Goethe University Frankfurt, Frankfurt, Germany
| | - W. S. Chan
- Queen Mary Hospital, High West, Hong Kong
| | | | - K. G. Ordovas
- University of California San Francisco, San Francisco, USA
| | | | - A. R. Patel
- University of Chicago Medicine, Chicago, USA
| | - V. A. Ferrari
- Hospital of the University of Pennsylvania, Philadelphia, USA
| |
Collapse
|
17
|
Hirshfeld JW, Ferrari VA, Bengel FM, Bergersen L, Chambers CE, Einstein AJ, Eisenberg MJ, Fogel MA, Gerber TC, Haines DE, Laskey WK, Limacher MC, Nichols KJ, Pryma DA, Raff GL, Rubin GD, Smith D, Stillman AE, Thomas SA, Tsai TT, Wagner LK, Wann LS. 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol 2018; 71:e283-e351. [PMID: 29729877 DOI: 10.1016/j.jacc.2018.02.016] [Citation(s) in RCA: 74] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
18
|
Kumarasamy N, Tishbi N, Mukundan S, Shiloh A, Levsky JM, Haramati LB. Cardiothoracic MRI in the ICU: A 10-Year Experience. Acad Radiol 2018; 25:359-364. [PMID: 29426683 DOI: 10.1016/j.acra.2017.09.017] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2017] [Revised: 09/26/2017] [Accepted: 09/27/2017] [Indexed: 11/29/2022]
Abstract
RATIONALE AND OBJECTIVE The objective of this study was to identify the feasibility and pitfalls of cardiothoracic magnetic resonance imaging (MRI) in intensive care unit (ICU) patients. MATERIALS AND METHODS This retrospective study identified adult ICU patients scheduled for cardiothoracic MRIs during a 10-year study period. ICU patients scheduled for brain MRIs served as a comparison group. A chart review was performed to identify factors impacting a patient's ability to undergo an MRI. Differences between completed and canceled examinations for both cardiothoracic and brain MRIs were evaluated. For the cardiothoracic group, clinical indications and the diagnostic value of the study performed were also identified. RESULTS A total of 143 cardiothoracic MRIs and 1011 brain MRIs were requested. Cardiothoracic MRI patients were less frequently completed (52% vs 62%), more frequently men (64% vs 43%), younger (55 vs 63 years), less likely mechanically ventilated (8% vs 29%), more likely to require intravenous contrast (83% vs 23%), and had longer examination times compared to brain MRI patients (64 vs 21 minutes). Successful completion of cardiothoracic MRI was associated with lower serum creatinine, higher glomerular filtration rate, and the absence of mechanical ventilation; significant differences were not seen with regard to gender and use of vasoactive agents. Cardiothoracic MRI results were diagnostic in 69% of examinations, most frequently when performed for myocardial disease (84%) and aortic disease (33%), and less frequently for viability (33%). CONCLUSIONS In an ICU population, successful completion of cardiothoracic MRI is challenging but feasible in patients with intact renal function and the absence of mechanical ventilation. Examinations were most frequently diagnostic for myocardial and aortic disease indications.
Collapse
Affiliation(s)
- Narmadan Kumarasamy
- Montefiore Medical Center, Albert Einstein College of Medicine, 111 E 210th St, Bronx, NY 10467.
| | - Nima Tishbi
- Montefiore Medical Center, Albert Einstein College of Medicine, 111 E 210th St, Bronx, NY 10467
| | - Shey Mukundan
- Montefiore Medical Center, Albert Einstein College of Medicine, 111 E 210th St, Bronx, NY 10467
| | - Ariel Shiloh
- Montefiore Medical Center, Albert Einstein College of Medicine, 111 E 210th St, Bronx, NY 10467
| | - Jeffrey M Levsky
- Montefiore Medical Center, Albert Einstein College of Medicine, 111 E 210th St, Bronx, NY 10467
| | - Linda B Haramati
- Montefiore Medical Center, Albert Einstein College of Medicine, 111 E 210th St, Bronx, NY 10467
| |
Collapse
|
19
|
Lu MT, Meyersohn NM, Mayrhofer T, Bittner DO, Emami H, Puchner SB, Foldyna B, Mueller ME, Hearne S, Yang C, Achenbach S, Truong QA, Ghoshhajra BB, Patel MR, Ferencik M, Douglas PS, Hoffmann U. Central Core Laboratory versus Site Interpretation of Coronary CT Angiography: Agreement and Association with Cardiovascular Events in the PROMISE Trial. Radiology 2017; 287:87-95. [PMID: 29178815 DOI: 10.1148/radiol.2017172181] [Citation(s) in RCA: 45] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Purpose To assess concordance and relative prognostic utility between central core laboratory and local site interpretation for significant coronary artery disease (CAD) and cardiovascular events. Materials and Methods In the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial, readers at 193 North American sites interpreted coronary computed tomographic (CT) angiography as part of the clinical evaluation of stable chest pain. Readers at a central core laboratory also interpreted CT angiography blinded to clinical data, site interpretation, and outcomes. Significant CAD was defined as stenosis greater than or equal to 50%; cardiovascular events were defined as a composite of cardiovascular death or myocardial infarction. Results In 4347 patients (51.8% women; mean age ± standard deviation, 60.4 years ± 8.2), core laboratory and site interpretations were discordant in 16% (683 of 4347), most commonly because of a finding of significant CAD by site but not by core laboratory interpretation (80%, 544 of 683). Overall, core laboratory interpretation resulted in 41% fewer patients being reported as having significant CAD (14%, 595 of 4347 vs 23%, 1000 of 4347; P < .001). Over a median follow-up period of 25 months, 1.3% (57 of 4347) sustained myocardial infarction or cardiovascular death. The C statistic for future myocardial infarction or cardiovascular death was 0.61 (95% confidence interval [CI]: 0.54, 0.68) for the core laboratory and 0.63 (95% CI: 0.56, 0.70) for the sites. Conclusion Compared with interpretation by readers at 193 North American sites, standardized core laboratory interpretation classified 41% fewer patients as having significant CAD. © RSNA, 2017 Online supplemental material is available for this article. Clinical trial registration no. NCT01174550.
Collapse
Affiliation(s)
- Michael T Lu
- From the Cardiac PET MR CT Program, Massachusetts General Hosp and Harvard Medical School, Boston, Mass (M.T.L., N.M.M., T.M., D.O.B., H.E., S.B.P., B.B.G., B.F., M.E.M., M.F., U.H.); School of Business Studies, Stralsund Univ of Applied Sciences, Stralsund, Germany (T.M.); Dept of Internal Medicine (Cardiology), Friedrich Alexander Univ Hosp, Erlangen, Germany (D.O.B., S.A.); Dept of Angiography and Interventional Radiology, Medical Univ Vienna, Vienna, Austria (S.B.P.); Delmarva Health LLC, Salisbury, Md (S.H.); Dept of Radiology, Univ of Connecticut Health Ctr, Farmington, Conn (C.Y.); Dalio Institute of Cardiovascular Imaging, Weill Cornell Medical College, New York, NY (Q.A.T.); Duke Clinical Research Inst, Duke Univ School of Medicine, Durham, NC (M.R.P., P.S.D.); and Knight Cardiovascular Inst, Oregon Health & Science Univ, Portland, Ore (M.F.)
| | - Nandini M Meyersohn
- From the Cardiac PET MR CT Program, Massachusetts General Hosp and Harvard Medical School, Boston, Mass (M.T.L., N.M.M., T.M., D.O.B., H.E., S.B.P., B.B.G., B.F., M.E.M., M.F., U.H.); School of Business Studies, Stralsund Univ of Applied Sciences, Stralsund, Germany (T.M.); Dept of Internal Medicine (Cardiology), Friedrich Alexander Univ Hosp, Erlangen, Germany (D.O.B., S.A.); Dept of Angiography and Interventional Radiology, Medical Univ Vienna, Vienna, Austria (S.B.P.); Delmarva Health LLC, Salisbury, Md (S.H.); Dept of Radiology, Univ of Connecticut Health Ctr, Farmington, Conn (C.Y.); Dalio Institute of Cardiovascular Imaging, Weill Cornell Medical College, New York, NY (Q.A.T.); Duke Clinical Research Inst, Duke Univ School of Medicine, Durham, NC (M.R.P., P.S.D.); and Knight Cardiovascular Inst, Oregon Health & Science Univ, Portland, Ore (M.F.)
| | - Thomas Mayrhofer
- From the Cardiac PET MR CT Program, Massachusetts General Hosp and Harvard Medical School, Boston, Mass (M.T.L., N.M.M., T.M., D.O.B., H.E., S.B.P., B.B.G., B.F., M.E.M., M.F., U.H.); School of Business Studies, Stralsund Univ of Applied Sciences, Stralsund, Germany (T.M.); Dept of Internal Medicine (Cardiology), Friedrich Alexander Univ Hosp, Erlangen, Germany (D.O.B., S.A.); Dept of Angiography and Interventional Radiology, Medical Univ Vienna, Vienna, Austria (S.B.P.); Delmarva Health LLC, Salisbury, Md (S.H.); Dept of Radiology, Univ of Connecticut Health Ctr, Farmington, Conn (C.Y.); Dalio Institute of Cardiovascular Imaging, Weill Cornell Medical College, New York, NY (Q.A.T.); Duke Clinical Research Inst, Duke Univ School of Medicine, Durham, NC (M.R.P., P.S.D.); and Knight Cardiovascular Inst, Oregon Health & Science Univ, Portland, Ore (M.F.)
| | - Daniel O Bittner
- From the Cardiac PET MR CT Program, Massachusetts General Hosp and Harvard Medical School, Boston, Mass (M.T.L., N.M.M., T.M., D.O.B., H.E., S.B.P., B.B.G., B.F., M.E.M., M.F., U.H.); School of Business Studies, Stralsund Univ of Applied Sciences, Stralsund, Germany (T.M.); Dept of Internal Medicine (Cardiology), Friedrich Alexander Univ Hosp, Erlangen, Germany (D.O.B., S.A.); Dept of Angiography and Interventional Radiology, Medical Univ Vienna, Vienna, Austria (S.B.P.); Delmarva Health LLC, Salisbury, Md (S.H.); Dept of Radiology, Univ of Connecticut Health Ctr, Farmington, Conn (C.Y.); Dalio Institute of Cardiovascular Imaging, Weill Cornell Medical College, New York, NY (Q.A.T.); Duke Clinical Research Inst, Duke Univ School of Medicine, Durham, NC (M.R.P., P.S.D.); and Knight Cardiovascular Inst, Oregon Health & Science Univ, Portland, Ore (M.F.)
| | - Hamed Emami
- From the Cardiac PET MR CT Program, Massachusetts General Hosp and Harvard Medical School, Boston, Mass (M.T.L., N.M.M., T.M., D.O.B., H.E., S.B.P., B.B.G., B.F., M.E.M., M.F., U.H.); School of Business Studies, Stralsund Univ of Applied Sciences, Stralsund, Germany (T.M.); Dept of Internal Medicine (Cardiology), Friedrich Alexander Univ Hosp, Erlangen, Germany (D.O.B., S.A.); Dept of Angiography and Interventional Radiology, Medical Univ Vienna, Vienna, Austria (S.B.P.); Delmarva Health LLC, Salisbury, Md (S.H.); Dept of Radiology, Univ of Connecticut Health Ctr, Farmington, Conn (C.Y.); Dalio Institute of Cardiovascular Imaging, Weill Cornell Medical College, New York, NY (Q.A.T.); Duke Clinical Research Inst, Duke Univ School of Medicine, Durham, NC (M.R.P., P.S.D.); and Knight Cardiovascular Inst, Oregon Health & Science Univ, Portland, Ore (M.F.)
| | - Stefan B Puchner
- From the Cardiac PET MR CT Program, Massachusetts General Hosp and Harvard Medical School, Boston, Mass (M.T.L., N.M.M., T.M., D.O.B., H.E., S.B.P., B.B.G., B.F., M.E.M., M.F., U.H.); School of Business Studies, Stralsund Univ of Applied Sciences, Stralsund, Germany (T.M.); Dept of Internal Medicine (Cardiology), Friedrich Alexander Univ Hosp, Erlangen, Germany (D.O.B., S.A.); Dept of Angiography and Interventional Radiology, Medical Univ Vienna, Vienna, Austria (S.B.P.); Delmarva Health LLC, Salisbury, Md (S.H.); Dept of Radiology, Univ of Connecticut Health Ctr, Farmington, Conn (C.Y.); Dalio Institute of Cardiovascular Imaging, Weill Cornell Medical College, New York, NY (Q.A.T.); Duke Clinical Research Inst, Duke Univ School of Medicine, Durham, NC (M.R.P., P.S.D.); and Knight Cardiovascular Inst, Oregon Health & Science Univ, Portland, Ore (M.F.)
| | - Borek Foldyna
- From the Cardiac PET MR CT Program, Massachusetts General Hosp and Harvard Medical School, Boston, Mass (M.T.L., N.M.M., T.M., D.O.B., H.E., S.B.P., B.B.G., B.F., M.E.M., M.F., U.H.); School of Business Studies, Stralsund Univ of Applied Sciences, Stralsund, Germany (T.M.); Dept of Internal Medicine (Cardiology), Friedrich Alexander Univ Hosp, Erlangen, Germany (D.O.B., S.A.); Dept of Angiography and Interventional Radiology, Medical Univ Vienna, Vienna, Austria (S.B.P.); Delmarva Health LLC, Salisbury, Md (S.H.); Dept of Radiology, Univ of Connecticut Health Ctr, Farmington, Conn (C.Y.); Dalio Institute of Cardiovascular Imaging, Weill Cornell Medical College, New York, NY (Q.A.T.); Duke Clinical Research Inst, Duke Univ School of Medicine, Durham, NC (M.R.P., P.S.D.); and Knight Cardiovascular Inst, Oregon Health & Science Univ, Portland, Ore (M.F.)
| | - Martin E Mueller
- From the Cardiac PET MR CT Program, Massachusetts General Hosp and Harvard Medical School, Boston, Mass (M.T.L., N.M.M., T.M., D.O.B., H.E., S.B.P., B.B.G., B.F., M.E.M., M.F., U.H.); School of Business Studies, Stralsund Univ of Applied Sciences, Stralsund, Germany (T.M.); Dept of Internal Medicine (Cardiology), Friedrich Alexander Univ Hosp, Erlangen, Germany (D.O.B., S.A.); Dept of Angiography and Interventional Radiology, Medical Univ Vienna, Vienna, Austria (S.B.P.); Delmarva Health LLC, Salisbury, Md (S.H.); Dept of Radiology, Univ of Connecticut Health Ctr, Farmington, Conn (C.Y.); Dalio Institute of Cardiovascular Imaging, Weill Cornell Medical College, New York, NY (Q.A.T.); Duke Clinical Research Inst, Duke Univ School of Medicine, Durham, NC (M.R.P., P.S.D.); and Knight Cardiovascular Inst, Oregon Health & Science Univ, Portland, Ore (M.F.)
| | - Steven Hearne
- From the Cardiac PET MR CT Program, Massachusetts General Hosp and Harvard Medical School, Boston, Mass (M.T.L., N.M.M., T.M., D.O.B., H.E., S.B.P., B.B.G., B.F., M.E.M., M.F., U.H.); School of Business Studies, Stralsund Univ of Applied Sciences, Stralsund, Germany (T.M.); Dept of Internal Medicine (Cardiology), Friedrich Alexander Univ Hosp, Erlangen, Germany (D.O.B., S.A.); Dept of Angiography and Interventional Radiology, Medical Univ Vienna, Vienna, Austria (S.B.P.); Delmarva Health LLC, Salisbury, Md (S.H.); Dept of Radiology, Univ of Connecticut Health Ctr, Farmington, Conn (C.Y.); Dalio Institute of Cardiovascular Imaging, Weill Cornell Medical College, New York, NY (Q.A.T.); Duke Clinical Research Inst, Duke Univ School of Medicine, Durham, NC (M.R.P., P.S.D.); and Knight Cardiovascular Inst, Oregon Health & Science Univ, Portland, Ore (M.F.)
| | - Clifford Yang
- From the Cardiac PET MR CT Program, Massachusetts General Hosp and Harvard Medical School, Boston, Mass (M.T.L., N.M.M., T.M., D.O.B., H.E., S.B.P., B.B.G., B.F., M.E.M., M.F., U.H.); School of Business Studies, Stralsund Univ of Applied Sciences, Stralsund, Germany (T.M.); Dept of Internal Medicine (Cardiology), Friedrich Alexander Univ Hosp, Erlangen, Germany (D.O.B., S.A.); Dept of Angiography and Interventional Radiology, Medical Univ Vienna, Vienna, Austria (S.B.P.); Delmarva Health LLC, Salisbury, Md (S.H.); Dept of Radiology, Univ of Connecticut Health Ctr, Farmington, Conn (C.Y.); Dalio Institute of Cardiovascular Imaging, Weill Cornell Medical College, New York, NY (Q.A.T.); Duke Clinical Research Inst, Duke Univ School of Medicine, Durham, NC (M.R.P., P.S.D.); and Knight Cardiovascular Inst, Oregon Health & Science Univ, Portland, Ore (M.F.)
| | - Stephan Achenbach
- From the Cardiac PET MR CT Program, Massachusetts General Hosp and Harvard Medical School, Boston, Mass (M.T.L., N.M.M., T.M., D.O.B., H.E., S.B.P., B.B.G., B.F., M.E.M., M.F., U.H.); School of Business Studies, Stralsund Univ of Applied Sciences, Stralsund, Germany (T.M.); Dept of Internal Medicine (Cardiology), Friedrich Alexander Univ Hosp, Erlangen, Germany (D.O.B., S.A.); Dept of Angiography and Interventional Radiology, Medical Univ Vienna, Vienna, Austria (S.B.P.); Delmarva Health LLC, Salisbury, Md (S.H.); Dept of Radiology, Univ of Connecticut Health Ctr, Farmington, Conn (C.Y.); Dalio Institute of Cardiovascular Imaging, Weill Cornell Medical College, New York, NY (Q.A.T.); Duke Clinical Research Inst, Duke Univ School of Medicine, Durham, NC (M.R.P., P.S.D.); and Knight Cardiovascular Inst, Oregon Health & Science Univ, Portland, Ore (M.F.)
| | - Quynh A Truong
- From the Cardiac PET MR CT Program, Massachusetts General Hosp and Harvard Medical School, Boston, Mass (M.T.L., N.M.M., T.M., D.O.B., H.E., S.B.P., B.B.G., B.F., M.E.M., M.F., U.H.); School of Business Studies, Stralsund Univ of Applied Sciences, Stralsund, Germany (T.M.); Dept of Internal Medicine (Cardiology), Friedrich Alexander Univ Hosp, Erlangen, Germany (D.O.B., S.A.); Dept of Angiography and Interventional Radiology, Medical Univ Vienna, Vienna, Austria (S.B.P.); Delmarva Health LLC, Salisbury, Md (S.H.); Dept of Radiology, Univ of Connecticut Health Ctr, Farmington, Conn (C.Y.); Dalio Institute of Cardiovascular Imaging, Weill Cornell Medical College, New York, NY (Q.A.T.); Duke Clinical Research Inst, Duke Univ School of Medicine, Durham, NC (M.R.P., P.S.D.); and Knight Cardiovascular Inst, Oregon Health & Science Univ, Portland, Ore (M.F.)
| | - Brian B Ghoshhajra
- From the Cardiac PET MR CT Program, Massachusetts General Hosp and Harvard Medical School, Boston, Mass (M.T.L., N.M.M., T.M., D.O.B., H.E., S.B.P., B.B.G., B.F., M.E.M., M.F., U.H.); School of Business Studies, Stralsund Univ of Applied Sciences, Stralsund, Germany (T.M.); Dept of Internal Medicine (Cardiology), Friedrich Alexander Univ Hosp, Erlangen, Germany (D.O.B., S.A.); Dept of Angiography and Interventional Radiology, Medical Univ Vienna, Vienna, Austria (S.B.P.); Delmarva Health LLC, Salisbury, Md (S.H.); Dept of Radiology, Univ of Connecticut Health Ctr, Farmington, Conn (C.Y.); Dalio Institute of Cardiovascular Imaging, Weill Cornell Medical College, New York, NY (Q.A.T.); Duke Clinical Research Inst, Duke Univ School of Medicine, Durham, NC (M.R.P., P.S.D.); and Knight Cardiovascular Inst, Oregon Health & Science Univ, Portland, Ore (M.F.)
| | - Manesh R Patel
- From the Cardiac PET MR CT Program, Massachusetts General Hosp and Harvard Medical School, Boston, Mass (M.T.L., N.M.M., T.M., D.O.B., H.E., S.B.P., B.B.G., B.F., M.E.M., M.F., U.H.); School of Business Studies, Stralsund Univ of Applied Sciences, Stralsund, Germany (T.M.); Dept of Internal Medicine (Cardiology), Friedrich Alexander Univ Hosp, Erlangen, Germany (D.O.B., S.A.); Dept of Angiography and Interventional Radiology, Medical Univ Vienna, Vienna, Austria (S.B.P.); Delmarva Health LLC, Salisbury, Md (S.H.); Dept of Radiology, Univ of Connecticut Health Ctr, Farmington, Conn (C.Y.); Dalio Institute of Cardiovascular Imaging, Weill Cornell Medical College, New York, NY (Q.A.T.); Duke Clinical Research Inst, Duke Univ School of Medicine, Durham, NC (M.R.P., P.S.D.); and Knight Cardiovascular Inst, Oregon Health & Science Univ, Portland, Ore (M.F.)
| | - Maros Ferencik
- From the Cardiac PET MR CT Program, Massachusetts General Hosp and Harvard Medical School, Boston, Mass (M.T.L., N.M.M., T.M., D.O.B., H.E., S.B.P., B.B.G., B.F., M.E.M., M.F., U.H.); School of Business Studies, Stralsund Univ of Applied Sciences, Stralsund, Germany (T.M.); Dept of Internal Medicine (Cardiology), Friedrich Alexander Univ Hosp, Erlangen, Germany (D.O.B., S.A.); Dept of Angiography and Interventional Radiology, Medical Univ Vienna, Vienna, Austria (S.B.P.); Delmarva Health LLC, Salisbury, Md (S.H.); Dept of Radiology, Univ of Connecticut Health Ctr, Farmington, Conn (C.Y.); Dalio Institute of Cardiovascular Imaging, Weill Cornell Medical College, New York, NY (Q.A.T.); Duke Clinical Research Inst, Duke Univ School of Medicine, Durham, NC (M.R.P., P.S.D.); and Knight Cardiovascular Inst, Oregon Health & Science Univ, Portland, Ore (M.F.)
| | - Pamela S Douglas
- From the Cardiac PET MR CT Program, Massachusetts General Hosp and Harvard Medical School, Boston, Mass (M.T.L., N.M.M., T.M., D.O.B., H.E., S.B.P., B.B.G., B.F., M.E.M., M.F., U.H.); School of Business Studies, Stralsund Univ of Applied Sciences, Stralsund, Germany (T.M.); Dept of Internal Medicine (Cardiology), Friedrich Alexander Univ Hosp, Erlangen, Germany (D.O.B., S.A.); Dept of Angiography and Interventional Radiology, Medical Univ Vienna, Vienna, Austria (S.B.P.); Delmarva Health LLC, Salisbury, Md (S.H.); Dept of Radiology, Univ of Connecticut Health Ctr, Farmington, Conn (C.Y.); Dalio Institute of Cardiovascular Imaging, Weill Cornell Medical College, New York, NY (Q.A.T.); Duke Clinical Research Inst, Duke Univ School of Medicine, Durham, NC (M.R.P., P.S.D.); and Knight Cardiovascular Inst, Oregon Health & Science Univ, Portland, Ore (M.F.)
| | - Udo Hoffmann
- From the Cardiac PET MR CT Program, Massachusetts General Hosp and Harvard Medical School, Boston, Mass (M.T.L., N.M.M., T.M., D.O.B., H.E., S.B.P., B.B.G., B.F., M.E.M., M.F., U.H.); School of Business Studies, Stralsund Univ of Applied Sciences, Stralsund, Germany (T.M.); Dept of Internal Medicine (Cardiology), Friedrich Alexander Univ Hosp, Erlangen, Germany (D.O.B., S.A.); Dept of Angiography and Interventional Radiology, Medical Univ Vienna, Vienna, Austria (S.B.P.); Delmarva Health LLC, Salisbury, Md (S.H.); Dept of Radiology, Univ of Connecticut Health Ctr, Farmington, Conn (C.Y.); Dalio Institute of Cardiovascular Imaging, Weill Cornell Medical College, New York, NY (Q.A.T.); Duke Clinical Research Inst, Duke Univ School of Medicine, Durham, NC (M.R.P., P.S.D.); and Knight Cardiovascular Inst, Oregon Health & Science Univ, Portland, Ore (M.F.)
| |
Collapse
|
20
|
Woroniecki RP, Kahnauth A, Panesar LE, Supe-Markovina K. Left Ventricular Hypertrophy in Pediatric Hypertension: A Mini Review. Front Pediatr 2017; 5:101. [PMID: 28553631 PMCID: PMC5425592 DOI: 10.3389/fped.2017.00101] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/28/2017] [Accepted: 04/20/2017] [Indexed: 12/17/2022] Open
Abstract
Adults with arterial hypertension (HTN) have stroke, myocardial infarction, end-stage renal disease (ESRD), or die at higher rates than those without. In children, HTN leads to target organ damage, which includes kidney, brain, eye, blood vessels, and heart, which precedes "hard outcomes" observed in adults. Left ventricular hypertrophy (LVH) or an anatomic and pathologic increase in left ventricular mass (LVM) in response to the HTN is a pediatric surrogate marker for HTN-induced morbidity and mortality in adults. This mini review discusses current definitions, clinically relevant methods of LVM measurements and normalization methods, its epidemiology, management, and issue of reversibility in children with HTN. Pediatric definition of LVH and abnormal LVM is not uniformed. With multiple definitions, prevalence of pediatric HTN-induced LVH is difficult to ascertain. In addition while in adults cardiac magnetic resonance imaging is considered "the gold standard" for LVM and LVH determination, pediatric data are limited to "special populations": ESRD, transplant, and obese children. We summarize available data on pediatric LVH treatment and reversibility and offer future directions in addressing LVH in children with HTN.
Collapse
Affiliation(s)
- Robert P Woroniecki
- Division of Pediatric Nephrology and Hypertension, Stony Brook Children's Hospital, School of Medicine, Stony Brook, NY, USA
| | | | - Laurie E Panesar
- Division of Pediatric Cardiology, Stony Brook Children's Hospital, School of Medicine, Stony Brook, NY, USA
| | - Katarina Supe-Markovina
- Division of Pediatric Nephrology and Hypertension, Stony Brook Children's Hospital, School of Medicine, Stony Brook, NY, USA
| |
Collapse
|
21
|
Bhambhvani P. The good, bad, and ugly of incidental findings on cardiovascular-computed tomography. J Nucl Cardiol 2016; 23:1275-1279. [PMID: 26204991 DOI: 10.1007/s12350-015-0244-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2015] [Accepted: 07/10/2015] [Indexed: 12/21/2022]
Affiliation(s)
- Pradeep Bhambhvani
- Division of Molecular Imaging and Therapeutics, Department of Radiology, The University of Alabama at Birmingham, Birmingham, AL, USA.
| |
Collapse
|
22
|
Abbara S, Blanke P, Maroules CD, Cheezum M, Choi AD, Han BK, Marwan M, Naoum C, Norgaard BL, Rubinshtein R, Schoenhagen P, Villines T, Leipsic J. SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: A report of the society of Cardiovascular Computed Tomography Guidelines Committee: Endorsed by the North American Society for Cardiovascular Imaging (NASCI). J Cardiovasc Comput Tomogr 2016; 10:435-449. [PMID: 27780758 DOI: 10.1016/j.jcct.2016.10.002] [Citation(s) in RCA: 652] [Impact Index Per Article: 81.5] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/05/2016] [Accepted: 10/09/2016] [Indexed: 01/20/2023]
Abstract
In response to recent technological advancements in acquisition techniques as well as a growing body of evidence regarding the optimal performance of coronary computed tomography angiography (coronary CTA), the Society of Cardiovascular Computed Tomography Guidelines Committee has produced this update to its previously established 2009 "Guidelines for the Performance of Coronary CTA" (1). The purpose of this document is to provide standards meant to ensure reliable practice methods and quality outcomes based on the best available data in order to improve the diagnostic care of patients. Society of Cardiovascular Computed Tomography Guidelines for the Interpretation is published separately (2). The Society of Cardiovascular Computed Tomography Guidelines Committee ensures compliance with all existing standards for the declaration of conflict of interest by all authors and reviewers for the purpose ofclarity and transparency.
Collapse
Affiliation(s)
- Suhny Abbara
- University of Texas Southwestern Medical Center, Dallas, TX, United States.
| | - Philipp Blanke
- Department of Radiology and Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada
| | | | - Michael Cheezum
- Cardiology Service Ft. Belvoir Community Hospital, Ft. Belvoir, VA, United States
| | - Andrew D Choi
- Division of Cardiology and Department of Radiology, The George Washington University School of Medicine, Washington DC, United States
| | - B Kelly Han
- Minneapolis Heart Institute and Children's Heart Clinic, Minneapolis, MN, United States
| | - Mohamed Marwan
- Cardiology Department, University Hospital, Erlangen, Germany
| | - Chris Naoum
- Concord Hospital, The University of Sydney, Sydney, Australia
| | - Bjarne L Norgaard
- Department of Cardiology B, Aarhus University Hospital-Skejby, Aarhus N, Denmark
| | - Ronen Rubinshtein
- Lady Davis Carmel Medical Center & Rappaport School of Medicine- Technion- IIT, Haifa, Israel
| | - Paul Schoenhagen
- Cardiovascular Imaging, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, United States
| | - Todd Villines
- Walter Reed National Military Medical Center, Bethesda, MD, United States
| | - Jonathon Leipsic
- Department of Radiology and Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada
| |
Collapse
|
23
|
Gleissner CA, Erbel C, Linden F, Domschke G, Akhavanpoor M, Doesch AO, Buss SJ, Giannitsis E, Katus HA, Korosoglou G. Galectin-3 binding protein plasma levels are associated with long-term mortality in coronary artery disease independent of plaque morphology. Atherosclerosis 2016; 251:94-100. [DOI: 10.1016/j.atherosclerosis.2016.06.002] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/23/2016] [Revised: 05/12/2016] [Accepted: 06/01/2016] [Indexed: 01/12/2023]
|
24
|
Gitsioudis G, Schmahl C, Missiou A, Voss A, Schüssler A, Abdel-Aty H, Buss SJ, Mueller D, Vembar M, Bryant M, Kauczor HU, Giannitsis E, Katus HA, Korosoglou G. Epicardial Adipose Tissue Is Associated with Plaque Burden and Composition and Provides Incremental Value for the Prediction of Cardiac Outcome. A Clinical Cardiac Computed Tomography Angiography Study. PLoS One 2016; 11:e0155120. [PMID: 27187590 PMCID: PMC4871366 DOI: 10.1371/journal.pone.0155120] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2016] [Accepted: 04/25/2016] [Indexed: 02/06/2023] Open
Abstract
Objectives We sought to investigate the association of epicardial adipose tissue (eCAT) volume with plaque burden, circulating biomarkers and cardiac outcomes in patients with intermediate risk for coronary artery disease (CAD). Methods and Results 177 consecutive outpatients at intermediate risk for CAD and completed biomarker analysis including high-sensitive Troponin T (hs-TnT) and hs-CRP underwent 256-slice cardiac computed tomography angiography (CCTA) between June 2008 and October 2011. Patients with lumen narrowing ≥50% exhibited significantly higher eCAT volume than patients without any CAD or lumen narrowing <50% (median (interquartile range, IQR): 108 (73–167) cm3 vs. 119 (82–196) cm3, p = 0.04). Multivariate regression analysis demonstrated an independent association eCAT volume with plaque burden by number of lesions (R2 = 0.22, rpartial = 0.29, p = 0.026) and CAD severity by lumen narrowing (R2 = 0.22, rpartial = 0.23, p = 0.038) after adjustment for age, diabetes mellitus, hyperlidipemia, body-mass-index (BMI), hs-CRP and hs-TnT. Univariate Cox proportional hazards regression analysis identified a significant association for both increased eCAT volume and maximal lumen narrowing with all cardiac events. Multivariate Cox proportional hazards regression analysis revealed an independent association of increased eCAT volume with all cardiac events after adjustment for age, >3 risk factors, presence of CAD, hs-CRP and hs-TnT. Conclusion Epicardial adipose tissue volume is independently associated with plaque burden and maximum luminal narrowing by CCTA and may serve as an independent predictor for cardiac outcomes in patients at intermediate risk for CAD.
Collapse
Affiliation(s)
- Gitsios Gitsioudis
- University of Heidelberg, Department of Cardiology, Heidelberg, Germany
- * E-mail:
| | - Christina Schmahl
- University of Heidelberg, Department of Cardiology, Heidelberg, Germany
| | - Anna Missiou
- University of Heidelberg, Department of Cardiology, Heidelberg, Germany
| | - Andreas Voss
- University of Heidelberg, Institute of Psychology, Heidelberg, Germany
| | - Alena Schüssler
- University of Heidelberg, Department of Cardiology, Heidelberg, Germany
| | - Hassan Abdel-Aty
- University of Heidelberg, Department of Cardiology, Heidelberg, Germany
| | - Sebastian J. Buss
- University of Heidelberg, Department of Cardiology, Heidelberg, Germany
| | - Dirk Mueller
- CT Clinical Science, Philips Healthcare GmbH, Hamburg, Germany
| | - Mani Vembar
- CT Clinical Science, Philips Healthcare, Cleveland, Ohio, United States of America
| | - Mark Bryant
- University of Heidelberg, Department of Diagnostic and Interventional Radiology, Heidelberg, Germany
| | - Hans-Ulrich Kauczor
- University of Heidelberg, Department of Diagnostic and Interventional Radiology, Heidelberg, Germany
| | | | - Hugo A. Katus
- University of Heidelberg, Department of Cardiology, Heidelberg, Germany
| | | |
Collapse
|
25
|
López-Sendón J, González-Juanatey JR, Pinto F, Cuenca Castillo J, Badimón L, Dalmau R, González Torrecilla E, López-Mínguez JR, Maceira AM, Pascual-Figal D, Pomar Moya-Prats JL, Sionis A, Zamorano JL. Indicadores de calidad en cardiología. Principales indicadores para medir la calidad de los resultados (indicadores de resultados) y parámetros de calidad relacionados con mejores resultados en la práctica clínica (indicadores de práctica asistencial). INCARDIO (Indicadores de Calidad en Unidades Asistenciales del Área del Corazón): Declaración de posicionamiento de consenso de SEC/SECTCV. CIRUGIA CARDIOVASCULAR 2015. [DOI: 10.1016/j.circv.2015.09.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
26
|
López-Sendón J, González-Juanatey JR, Pinto F, Cuenca Castillo J, Badimón L, Dalmau R, González Torrecilla E, López-Mínguez JR, Maceira AM, Pascual-Figal D, Pomar Moya-Prats JL, Sionis A, Zamorano JL. Indicadores de calidad en cardiología. Principales indicadores para medir la calidad de los resultados (indicadores de resultados) y parámetros de calidad relacionados con mejores resultados en la práctica clínica (indicadores de práctica asistencial). INCARDIO (Indicadores de Calidad en Unidades Asistenciales del Área del Corazón): Declaración de posicionamiento de consenso de SEC/SECTCV. Rev Esp Cardiol 2015. [DOI: 10.1016/j.recesp.2015.07.005] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
|
27
|
|
28
|
López-Sendón J, González-Juanatey JR, Pinto F, Cuenca Castillo J, Badimón L, Dalmau R, González Torrecilla E, López-Mínguez JR, Maceira AM, Pascual-Figal D, Pomar Moya-Prats JL, Sionis A, Zamorano JL. Quality Markers in Cardiology. Main Markers to Measure Quality of Results (Outcomes) and Quality Measures Related to Better Results in Clinical Practice (Performance Metrics). INCARDIO (Indicadores de Calidad en Unidades Asistenciales del Área del Corazón): A SEC/SECTCV Consensus Position Paper. ACTA ACUST UNITED AC 2015; 68:976-995.e10. [PMID: 26315766 DOI: 10.1016/j.rec.2015.07.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2015] [Accepted: 07/21/2015] [Indexed: 02/06/2023]
Abstract
Cardiology practice requires complex organization that impacts overall outcomes and may differ substantially among hospitals and communities. The aim of this consensus document is to define quality markers in cardiology, including markers to measure the quality of results (outcomes metrics) and quality measures related to better results in clinical practice (performance metrics). The document is mainly intended for the Spanish health care system and may serve as a basis for similar documents in other countries.
Collapse
Affiliation(s)
- José López-Sendón
- Servicio de Cardiología, Hospital Universitario La Paz, IdiPaz, Madrid, Spain.
| | - José Ramón González-Juanatey
- Sociedad Española de Cardiología, Madrid, Spain; Servicio de Cardiología, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, Spain
| | - Fausto Pinto
- European Society of Cardiology; Department of Cardiology, University Hospital Santa Maria, Lisbon, Portugal
| | - José Cuenca Castillo
- Sociedad Española de Cirugía Torácica-Cardiovascular; Servicio de Cirugía Cardiaca, Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain
| | - Lina Badimón
- Centro de Investigación Cardiovascular (CSIC-ICCC), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| | - Regina Dalmau
- Unidad de Rehabilitación Cardiaca, Servicio de Cardiología, Hospital Universitario La Paz, IdiPaz, Madrid, Spain
| | - Esteban González Torrecilla
- Unidad de Electrofisiología y Arritmias, Servicio de Cardiología, Hospital Universitario Gregorio Marañón, Madrid, Spain
| | - José Ramón López-Mínguez
- Unidad de Cardiología intervencionista, Servicio de Cardiología, Hospital Infanta Crsitina, Badajoz, Spain
| | - Alicia M Maceira
- Unidad de Imagen Cardiaca, Servicio de Cardiología, ERESA Medical Center, Valencia, Spain
| | - Domingo Pascual-Figal
- Servicio de Cardiología, Hospital Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain
| | | | - Alessandro Sionis
- Unidad de Cuidados Intensivos Cardiológicos, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| | - José Luis Zamorano
- Servicio de Cardiología, Hospital Universitario Ramón y Cajal, Madrid, Spain
| | | |
Collapse
|
29
|
Garcia MJ, Blankstein R, Budoff MJ, Dent JM, Drachman DE, Lesser JR, Grover-McKay M, Schussler JM, Voros S, Wann LS. COCATS 4 Task Force 7: Training in Cardiovascular Computed Tomographic Imaging : Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Atherosclerosis Imaging and Prevention, and the Society of Cardiovascular Computed Tomography. J Nucl Cardiol 2015; 22:826-39. [PMID: 26134884 DOI: 10.1007/s12350-015-0163-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- Mario J Garcia
- Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA,
| | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Gitsioudis G, Schüssler A, Nagy E, Maurovich-Horvat P, Buss SJ, Voss A, Hosch W, Hofmann N, Kauczor HU, Giannitsis E, Katus HA, Korosoglou G. Combined Assessment of High-Sensitivity Troponin T and Noninvasive Coronary Plaque Composition for the Prediction of Cardiac Outcomes. Radiology 2015; 276:73-81. [DOI: 10.1148/radiol.15141110] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/30/2023]
|
31
|
Monmeneu Menadas JV, Lopez-Lereu MP, Estornell Erill J, Garcia Gonzalez P, Igual Muñoz B, Maceira Gonzalez A. Pharmacological stress cardiovascular magnetic resonance: feasibility and safety in a large multicentre prospective registry. Eur Heart J Cardiovasc Imaging 2015; 17:308-15. [PMID: 26108417 DOI: 10.1093/ehjci/jev153] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/08/2015] [Accepted: 05/23/2015] [Indexed: 11/13/2022] Open
Abstract
AIMS To assess the feasibility and incidence of immediate complications of stress cardiovascular magnetic resonance (CMR) and to determine associated factors. METHODS AND RESULTS This was a large multicentre, prospective registry of pharmacologic stress CMR in a referral population. We used dipyridamole when no contraindication was present and dobutamine in the remaining patients. Stress CMR was performed at 1.5 T. We recorded the clinical and demographic data, quality of test, CMR findings, haemodynamic data, and complications. Stress CMR was performed in 11 984 patients (98.2% of requested), using dipyridamole in 95.4% and dobutamine in 4.6%. The study could not be performed due to claustrophobia in 0.2%. Quality was optimal in 93.4%, suboptimal in 6.2%, and poor in 0.4% of studies. Images were diagnostic in 97.6% of patients (98.7% with dipyridamole and 75.1% with dobutamine, P < 0.0001). No patient died or had acute myocardial infarction during the test. Ten patients (0.08%) had severe immediate complications, seven after dipyridamole and two after dobutamine (P = 0.062), and one anaphylactic shock post-gadolinium. The only factor significantly associated with higher incidence of serious complications was the detection of inducible ischaemia. Incidence of non-severe complications was low (1.5%), severe controlled chest pain being the most frequent. Minor symptoms occurred frequently (24.8%). Both were significantly more frequent when dobutamine was used. CONCLUSION Performance of stress CMR is safe in a referral population. Inducible ischaemia was the only factor identified which was associated with serious complications. The incidence of non-severe complications and minor symptoms was greater with dobutamine.
Collapse
|
32
|
|
33
|
Srivastava S, Printz BF, Geva T, Shirali GS, Weinberg PM, Wong PC, Lang P. Task Force 2: Pediatric Cardiology Fellowship Training in Noninvasive Cardiac Imaging. J Am Coll Cardiol 2015; 66:687-98. [PMID: 25777631 DOI: 10.1016/j.jacc.2015.03.010] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
34
|
Garcia MJ, Blankstein R, Budoff MJ, Dent JM, Drachman DE, Lesser JR, Grover-McKay M, Schussler JM, Voros S, Wann LS. COCATS 4 Task Force 7: Training in Cardiovascular Computed Tomographic Imaging. J Am Coll Cardiol 2015; 65:1810-21. [PMID: 25777650 DOI: 10.1016/j.jacc.2015.03.028] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
35
|
|
36
|
Parisi R, Mirabella F, Secco GG, Fattori R. Multimodality imaging in apical hypertrophic cardiomyopathy. World J Cardiol 2014; 6:916-923. [PMID: 25276293 PMCID: PMC4176801 DOI: 10.4330/wjc.v6.i9.916] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/29/2014] [Revised: 04/02/2014] [Accepted: 07/15/2014] [Indexed: 02/06/2023] Open
Abstract
Apical hypertrophic cardiomyopathy (AHCM) is a relatively rare morphologic variant of HCM in which the hypertrophy of myocardium is localized to the left ventricular apex. Symptoms of AHCM might vary from none to others mimic coronary artery disease including acute coronary syndrome, thus resulting in inappropriate hospitalization. Transthoracic echocardiography is the first-line imaging technique for the diagnosis of hypertrophic cardiomyopathies. However, when the hypertrophy of the myocardium is localized in the ventricular apex might results in missed diagnosis. Aim of this paper is to review the different imaging techniques used for the diagnosis of AHCM and their role in the detection and comprehension of this uncommon disease.
Collapse
|
37
|
Leipsic J, Abbara S, Achenbach S, Cury R, Earls JP, Mancini GBJ, Nieman K, Pontone G, Raff GL. SCCT guidelines for the interpretation and reporting of coronary CT angiography: A report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr 2014; 8:342-58. [PMID: 25301040 DOI: 10.1016/j.jcct.2014.07.003] [Citation(s) in RCA: 712] [Impact Index Per Article: 71.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/20/2014] [Accepted: 07/21/2014] [Indexed: 12/18/2022]
|
38
|
Maffei E, Arcadi T, Zuccarelli A, Clemente A, Torri T, Rossi P, Seitun S, Catalano O, Cademartiri F. The impact of training on diagnostic accuracy with computed tomography coronary angiography. J Cardiovasc Med (Hagerstown) 2014; 14:719-25. [PMID: 24335883 DOI: 10.2459/jcm.0b013e32835ec746] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
AIM The aim of this study is to assess the image quality and diagnostic accuracy of computed tomography (CT) coronary angiography (CTCA) in different hospital settings with the same trained team. MATERIALS AND METHODS Four hundred patients were consecutively enrolled for CTCA in a large academic hospital (Group 1; Sensation 64 Cardiac, Siemens - Iomeprol 400, Bracco; 200 patients) and in a small local hospital (Group 2; VCT, GE Healthcare - Iodixanol 320, GE Healthcare; 200 patients). All patients were enrolled for suspected coronary artery disease (CAD) and patients with stents or who had previously undergone coronary bypass were excluded. Scan protocols (retrospectively ECG-gated; no dose reduction modulation applied) were performed in accordance with standards reported in the international literature with the best solution available on site. Image quality was assessed in each coronary segment with a 4-point Likert scale: 0, not assessable; 1, low; 2, average; 3, good. Diagnostic accuracy was calculated against conventional coronary angiography with a threshold of at least 50% for significant stenosis. RESULTS There was no significant difference between demographics, BMI, prevalence of obstructive CAD, calcium score and heart rate between the two populations. The average image quality was 2.83 ± 0.37 for Group 1 and 2.86 ± 0.31 for Group 2 (P > 0.05). Per-segment sensitivity, specificity, positive and negative predictive values were 92.6% (87-95), 97.9% (97-98), 75.9% (69-81) and 99.5% (99-99), respectively, for Group 1, and 90.4% (85-93), 98.6% (98-99), 84.2% (78-88) and 99.2% (98-99), respectively, for Group 2 (P > 0.05). CONCLUSION There is no significant difference in image quality and diagnostic accuracy of CTCA when the investigation is performed by the same properly trained team. CTCA is a robust imaging modality for the detection of coronary artery stenosis.
Collapse
Affiliation(s)
- Erica Maffei
- aDepartment of Radiology, Giovanni XXIII Clinic, Monastier di Treviso (TV) bDepartment of Radiology, Ospedale di Carrara, Carrara, Italy cDepartment of Radiology and Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands dDepartment of Radiology, SDN-IRCCS, Napoli, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Raff GL, Chinnaiyan KM, Cury RC, Garcia MT, Hecht HS, Hollander JE, O'Neil B, Taylor AJ, Hoffmann U. SCCT guidelines on the use of coronary computed tomographic angiography for patients presenting with acute chest pain to the emergency department: A Report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr 2014; 8:254-71. [DOI: 10.1016/j.jcct.2014.06.002] [Citation(s) in RCA: 73] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/03/2014] [Accepted: 06/04/2014] [Indexed: 02/06/2023]
|
40
|
O'Brien J, Al-Hassan D, Ng J, Joshi M, Hague C, Chakrabarti S, Leipsic J. Three-dimensional assessment of left atrial appendage orifice geometry and potential implications for device closure. Int J Cardiovasc Imaging 2014; 30:819-23. [PMID: 24599646 DOI: 10.1007/s10554-014-0393-0] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/25/2013] [Accepted: 02/25/2014] [Indexed: 10/25/2022]
Abstract
Transcatheter placement of left atrial closure device is an attractive therapy for patients with atrial fibrillation (AF), to avoid anticoagulation and reduce cerebrovascular events; however peri-device leaks occur. The geometry of the left atrial appendage (LAA) is not well understood, largely owing to limitations of 2-dimensional imaging techniques. We sought to better define the LAA orifice geometry, by performing 3-dimensional multi-detector computed tomography measurements. We prospectively recruited 105 consecutive patients referred for pulmonary vein ablation (PVA) and age-matched controls. Area, short and long-axis measurements were performed. Eccentricity was calculated as 1-(short axis/long axis). Multiple clinical variables were tested for their ability to predict appendage orifice eccentricity using univariate linear regression models. The PVA cohort demographics included; 25 (24%) females, mean age 59 years (SD = 10), median height (1.55-2.03), weight 89 (56-139) kg and body surface area 2.1 (1.61-2.58). In the PVA cohort, there was a significant difference between the long and short-axis; median short-axis dimension was 20.5 (12.9-35.4) mm, versus long-axis median 30.4 (17.7-43.8) (p < 0.001). Mean eccentricity score was 0.4. When compared with controls, there was a significant difference in the short and long-axis measurements (p < 0.001) as well as eccentricity (p = 0.04). All clinical variables tested showed limited ability to predict appendage eccentricity (p = NS). LAA ostium is an elliptical structure in the setting of AF with a high eccentricity index and uniformly significant differences between short and long-axis. There were significant differences between these parameters when compared with controls. A deeper appreciation of LAA geometry and eccentricity may allow for reduction in peri-closure leaks.
Collapse
Affiliation(s)
- Julie O'Brien
- Cardiac Imaging Division, Department of Radiology, St. Paul's Hospital, 1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada,
| | | | | | | | | | | | | |
Collapse
|
41
|
Kliger C, Jelnin V, Sharma S, Panagopoulos G, Einhorn BN, Kumar R, Cuesta F, Maranan L, Kronzon I, Carelsen B, Cohen H, Perk G, Van Den Boomen R, Sahyoun C, Ruiz CE. CT angiography-fluoroscopy fusion imaging for percutaneous transapical access. JACC Cardiovasc Imaging 2014; 7:169-77. [PMID: 24412189 DOI: 10.1016/j.jcmg.2013.10.009] [Citation(s) in RCA: 51] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/25/2013] [Revised: 09/09/2013] [Accepted: 10/03/2013] [Indexed: 12/22/2022]
Abstract
OBJECTIVES The aim of this proof-of-principle study is to validate the accuracy of fusion imaging for percutaneous transapical access (TA). BACKGROUND Structural heart disease interventions, including TA, are commonly obtained under fluoroscopic guidance, which lacks important spatial information. Computed tomographic angiography (CTA)-fluoroscopy fusion imaging can provide the 3-dimensional information necessary for improved accuracy in planning and guidance of these interventions. METHODS Twenty consecutive patients scheduled for percutaneous left ventricular puncture and device closure using CTA-fluoroscopy fusion guidance were prospectively recruited. The HeartNavigator software (Philips Healthcare, Best, the Netherlands) was used to landmark the left ventricular epicardium for TA (planned puncture site [PPS]). The PPS landmark was compared with the position of the TA closure device on post-procedure CTA (actual puncture site). The distance between the PPS and actual puncture site was calculated from 2 fixed reference points (left main ostium and mitral prosthesis center) in 3 planes (x, y, and z). The distance from the left anterior descending artery at the same z-plane was also assessed. TA-related complications associated with fusion imaging were recorded. RESULTS The median (interquartile range [IQR]) TA distance difference between the PPS and actual puncture site from the referenced left main ostium and mitral prosthesis center was 5.00 mm (IQR: 1.98 to 12.64 mm) and 3.27 mm (IQR: 1.88 to 11.24 mm) in the x-plane, 4.48 mm (IQR: 1.98 to 13.08 mm) and 4.00 mm (IQR: 1.62 to 11.86 mm) in the y-plane, and 5.57 mm (IQR: 3.89 to 13.62 mm) and 4.96 mm (IQR: 1.92 to 11.76 mm) in the z-plane. The mean TA distance to the left anterior descending artery was 15.5 ± 7.8 mm and 22.7 ± 13.7 mm in the x- and y-planes. No TA-related complications were identified, including evidence of coronary artery laceration. CONCLUSIONS With the use of CTA-fluoroscopy fusion imaging to guide TA, the actual puncture site can be approximated near the PPS. Moreover, fusion imaging can help maintain an adequate access distance from the left anterior descending artery, thereby, potentially reducing TA-related complications.
Collapse
Affiliation(s)
- Chad Kliger
- Department of Cardiovascular Medicine, Division of Structural and Congenital Heart Disease, Lenox Hill Heart and Vascular Institute-North Shore/Long Island Jewish Health System, New York, New York
| | - Vladimir Jelnin
- Department of Cardiovascular Medicine, Division of Structural and Congenital Heart Disease, Lenox Hill Heart and Vascular Institute-North Shore/Long Island Jewish Health System, New York, New York
| | - Sonnit Sharma
- Department of Cardiovascular Medicine, Division of Structural and Congenital Heart Disease, Lenox Hill Heart and Vascular Institute-North Shore/Long Island Jewish Health System, New York, New York
| | - Georgia Panagopoulos
- Department of Cardiovascular Medicine, Division of Structural and Congenital Heart Disease, Lenox Hill Heart and Vascular Institute-North Shore/Long Island Jewish Health System, New York, New York
| | - Bryce N Einhorn
- Department of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania
| | - Robert Kumar
- Department of Cardiovascular Medicine, Division of Structural and Congenital Heart Disease, Lenox Hill Heart and Vascular Institute-North Shore/Long Island Jewish Health System, New York, New York
| | - Francisco Cuesta
- Department of Cardiovascular Medicine, Division of Structural and Congenital Heart Disease, Lenox Hill Heart and Vascular Institute-North Shore/Long Island Jewish Health System, New York, New York
| | - Leandro Maranan
- Department of Cardiovascular Medicine, Division of Structural and Congenital Heart Disease, Lenox Hill Heart and Vascular Institute-North Shore/Long Island Jewish Health System, New York, New York
| | - Itzhak Kronzon
- Department of Cardiovascular Medicine, Division of Structural and Congenital Heart Disease, Lenox Hill Heart and Vascular Institute-North Shore/Long Island Jewish Health System, New York, New York
| | - Bart Carelsen
- Clinical Science Division, Philips Healthcare, Best, the Netherlands
| | - Howard Cohen
- Department of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania
| | - Gila Perk
- Department of Cardiovascular Medicine, Division of Structural and Congenital Heart Disease, Lenox Hill Heart and Vascular Institute-North Shore/Long Island Jewish Health System, New York, New York
| | | | - Cherif Sahyoun
- Clinical Science Division, Philips Healthcare, Best, the Netherlands
| | - Carlos E Ruiz
- Department of Cardiovascular Medicine, Division of Structural and Congenital Heart Disease, Lenox Hill Heart and Vascular Institute-North Shore/Long Island Jewish Health System, New York, New York.
| |
Collapse
|
42
|
Ntsinjana HN, Tann O, Taylor AM. Trends in pediatric cardiovascular magnetic resonance imaging. Acta Radiol 2013; 54:1063-74. [PMID: 23390156 DOI: 10.1177/0284185113475609] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Cardiac magnetic resonance (CMR) imaging has significantly evolved over the last decade, becoming an integral part of the contemporary assessment of both congenital and acquired pediatric heart disease. Recent trends show that there is a growing interest in clinical applications and research in this field. An attempt to discuss the evolving technologies, techniques, and applications of CMR in pediatrics is not complete without understanding the current strengths of the modality. CMR complements readily available echocardiography, in many cases information from CMR can remove the need for invasive angiographic catheterization, and in other cases can be used to augment cardiac catheterisation.
Collapse
Affiliation(s)
- Hopewell N Ntsinjana
- Centre for Cardiovascular Imaging, UCL
Institute of Cardiovascular Sciences, London
- Cardiorespiratory Unit, Great Ormond
Street Hospital for Children, London, UK
| | - Oliver Tann
- Centre for Cardiovascular Imaging, UCL
Institute of Cardiovascular Sciences, London
- Cardiorespiratory Unit, Great Ormond
Street Hospital for Children, London, UK
| | - Andrew M Taylor
- Centre for Cardiovascular Imaging, UCL
Institute of Cardiovascular Sciences, London
- Cardiorespiratory Unit, Great Ormond
Street Hospital for Children, London, UK
| |
Collapse
|
43
|
Rationale and design of the HeartFlowNXT (HeartFlow analysis of coronary blood flow using CT angiography: NeXt sTeps) study. J Cardiovasc Comput Tomogr 2013; 7:279-88. [PMID: 24268114 DOI: 10.1016/j.jcct.2013.09.003] [Citation(s) in RCA: 58] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/18/2013] [Revised: 09/03/2013] [Accepted: 09/26/2013] [Indexed: 12/20/2022]
Abstract
INTRODUCTION Coronary CT angiography (CTA) is an established noninvasive method for visualization of coronary artery disease. However, coronary CTA lacks physiological information; thus, it does not permit differentiation of ischemia-causing lesions. Recent advances in computational fluid dynamic techniques applied to standard coronary CTA images allow for computation of fractional flow reserve (FFR), a measure of lesion-specific ischemia. The diagnostic performance of computed FFR (FFRCT) compared with invasively measured FFR is not yet fully established. METHODS/DESIGN HeartFlowNXT (HeartFlow analysis of coronary blood flow using coronary CT angiography: NeXt sTeps) is a prospective, international, multicenter study designed to evaluate the diagnostic performance of FFRCT for the detection and exclusion of flow-limiting obstructive coronary stenoses, as defined by invasively measured FFR as the reference standard. FFR values ≤ 0.80 will be considered to be ischemia causing. All subjects (N = 270; 10 investigative sites) will undergo coronary CTA (single- or dual-source CT scanners with a minimum of 64 slices) and invasive coronary angiography with FFR. Patients with insufficient quality of coronary CTA will be excluded. Blinded core laboratory interpretation will be performed for FFRCT, invasive coronary angiography, and FFR. Stenosis severity by coronary CTA will be evaluated by the investigative site in addition to a blinded core laboratory interpretation. The primary objective of the study is to determine the diagnostic performance of FFRCT compared with coronary CTA alone to noninvasively determine the presence of hemodynamically significant coronary lesions. The secondary end point comprises assessment of diagnostic accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of FFRCT.
Collapse
|
44
|
Dorbala S, Di Carli MF, Delbeke D, Abbara S, DePuey EG, Dilsizian V, Forrester J, Janowitz W, Kaufmann PA, Mahmarian J, Moore SC, Stabin MG, Shreve P. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med 2013; 54:1485-507. [PMID: 23781013 DOI: 10.2967/jnumed.112.105155] [Citation(s) in RCA: 157] [Impact Index Per Article: 14.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
|
45
|
Leipsic J, Taylor CM, Grunau G, Heilbron BG, Mancini GBJ, Achenbach S, Al-Mallah M, Berman DS, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng VY, Chinnaiyan K, Chow BJW, Delago A, Hadamitzky M, Hausleiter J, Cury R, Feuchtner G, Kim YJ, Kaufmann PA, Lin FY, Maffei E, Raff G, Shaw LJ, Villines TC, Min JK. Cardiovascular Risk among Stable Individuals Suspected of Having Coronary Artery Disease with No Modifiable Risk Factors: Results from an International Multicenter Study of 5262 Patients. Radiology 2013; 267:718-26. [DOI: 10.1148/radiol.13121669] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
46
|
Stress CMR reduces revascularization, hospital readmission, and recurrent cardiac testing in intermediate-risk patients with acute chest pain. JACC Cardiovasc Imaging 2013; 6:785-94. [PMID: 23664718 DOI: 10.1016/j.jcmg.2012.11.022] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/21/2012] [Accepted: 11/01/2012] [Indexed: 11/20/2022]
Abstract
OBJECTIVES The aim of this study was to determine the effect of stress cardiac magnetic resonance (CMR) imaging in an observation unit (OU) on revascularization, hospital readmission, and recurrent cardiac testing in intermediate-risk patients with possible acute coronary syndromes (ACS). BACKGROUND Intermediate-risk patients commonly undergo hospital admission with high rates of coronary revascularization. It is unknown whether OU-based care with CMR is a more efficient alternative. METHODS A total of 105 intermediate-risk participants with symptoms of ACS but without definite ACS on the basis of the first electrocardiogram and troponin were randomized to usual care provided by cardiologists and internists (n = 53) or to OU care with stress CMR (n = 52). The primary composite endpoint of coronary artery revascularization, hospital readmission, and recurrent cardiac testing at 90 days was determined. The secondary endpoint was length of stay from randomization to index visit discharge; safety was measured as ACS after discharge. RESULTS The median age of participants was 56 years (range 35 to 91 years), 54% were men, and 20% had pre-existing coronary disease. Index hospital admission was avoided in 85% of the OU CMR participants. The primary outcome occurred in 20 usual care participants (38%) versus 7 OU CMR participants (13%) (hazard ratio: 3.4; 95% confidence interval: 1.4 to 8.0, p = 0.006). The OU CMR group experienced significant reductions in all components: revascularizations (15% vs. 2%, p = 0.03), hospital readmissions (23% vs. 8%, p = 0.03), and recurrent cardiac testing (17% vs. 4%, p = 0.03). Median length of stay was 26 h (interquartile range: 23 to 45 h) in the usual care group and 21 h (interquartile range: 15 to 25 h) in the OU CMR group (p < 0.001). ACS after discharge occurred in 3 usual care participants (6%) and no OU CMR participants. CONCLUSIONS In this single-center trial, management of intermediate-risk patients with possible ACS in an OU with stress CMR reduced coronary artery revascularization, hospital readmissions, and recurrent cardiac testing, without an increase in post-discharge ACS at 90 days. (Randomized Investigation of Chest Pain Diagnostic Strategies; NCT01035047).
Collapse
|
47
|
Vafaie M, Biener M, Mueller M, Schnabel PA, André F, Steen H, Zorn M, Schueler M, Blankenberg S, Katus HA, Giannitsis E. Analytically false or true positive elevations of high sensitivity cardiac troponin: a systematic approach. Heart 2013; 100:508-14. [DOI: 10.1136/heartjnl-2012-303202] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
48
|
Athanasiadis A, Schneider B, Sechtem U. Role of Cardiovascular Magnetic Resonance in Takotsubo Cardiomyopathy. Heart Fail Clin 2013; 9:167-76, viii. [DOI: 10.1016/j.hfc.2012.12.011] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
49
|
Otsuka K, Fukuda S, Tanaka A, Nakanishi K, Taguchi H, Yoshikawa J, Shimada K, Yoshiyama M. Napkin-ring sign on coronary CT angiography for the prediction of acute coronary syndrome. JACC Cardiovasc Imaging 2013; 6:448-57. [PMID: 23498679 DOI: 10.1016/j.jcmg.2012.09.016] [Citation(s) in RCA: 242] [Impact Index Per Article: 22.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/30/2012] [Revised: 08/13/2012] [Accepted: 09/27/2012] [Indexed: 10/27/2022]
Abstract
OBJECTIVES The aim of this study was to determine the predictive value of the napkin-ring sign on coronary computed tomography angiography (CTA) for future acute coronary syndrome (ACS) events in patients with coronary artery disease. BACKGROUND Recent studies have reported a close association between the napkin-ring sign on coronary CTA and thin-cap fibroatheroma. METHODS The subjects of this prospective study were 895 consecutive patients who underwent coronary CTA examination and were followed for >1 year. The primary endpoint was an ACS event (cardiac death, nonfatal myocardial infarction, or unstable angina pectoris). The coronary CTA analysis included the presence of obstructive plaque, positive remodeling (PR), low-attenuation plaque (LAP), and the napkin-ring sign. The napkin-ring sign was defined by the following criteria: 1) the presence of a ring of high attenuation around certain coronary artery plaques; and 2) attenuation of the ring presenting higher than those of the adjacent plaque and no >130 Hounsfield units. RESULTS Of the 12,727 segments, 1,174 plaques were observed, including plaques with PR in 130 segments (1.0%), LAP in 107 segments (0.8%), and napkin-ring signs in 45 segments (0.4%). Thirty-six of the 45 plaques with napkin-ring signs (80%) overlapped with those showing either PR or LAP. During the follow-up period (2.3 ± 0.8 years), 24 patients (2.6%) experienced ACS events, and plaques developed in 41% with a napkin-ring sign. Segment-based Cox proportional hazards models analysis showed that PR (p < 0.001), LAP (p = 0.007), and the napkin-ring sign (p < 0.0001) were independent predictive factors for future ACS events. Kaplan-Meier analysis demonstrated that plaques with napkin-ring signs showed a higher risk of ACS events compared with those without a napkin-ring sign. CONCLUSIONS The present study demonstrated for the first time that the napkin-ring sign demonstrated on coronary CTA was strongly associated with future ACS events, independent of other high-risk coronary CTA features. Detection of the napkin-ring sign could help identify coronary artery disease patients at high risk of future ACS events.
Collapse
Affiliation(s)
- Kenichiro Otsuka
- Department of Internal Medicine and Cardiology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | | | | | | | | | | | | | | |
Collapse
|
50
|
Leipsic J, LaBounty TM, Ajlan AM, Earls JP, Strovski E, Madden M, Wood DA, Hague CJ, Poulter R, Branch K, Cury RC, Heilbron B, Taylor C, Grunau G, Haiducu L, Min JK. A prospective randomized trial comparing image quality, study interpretability, and radiation dose of narrow acquisition window with widened acquisition window protocols in prospectively ECG-triggered coronary computed tomography angiography. J Cardiovasc Comput Tomogr 2013; 7:18-24. [DOI: 10.1016/j.jcct.2013.01.001] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/11/2012] [Revised: 08/29/2012] [Accepted: 01/06/2013] [Indexed: 10/27/2022]
|